Characterization	O
of	O
peripheral	B-cell_type
blood	I-cell_type
T-lymphocytes	I-cell_type
transduced	O
with	O
HTLV-I	B-protein
Tax	I-protein
mutants	I-protein
with	O
different	O
trans-activating	O
phenotypes	O
.	O

Tax1	B-protein
,	O
a	O
transcriptional	B-protein
trans-activator	I-protein
of	O
the	O
Human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
,	O
induces	O
the	O
expression	O
of	O
many	O
cellular	O
genes	O
through	O
interaction	O
with	O
at	O
least	O
three	O
distinct	O
cellular	B-protein
transcription	I-protein
factors	I-protein
;	O
CREB/ATF	B-protein
,	O
NF-kappaB	B-protein
,	O
and	O
SRF	B-protein
.	O

This	O
Tax1	B-protein
-induced	O
activation	O
of	O
cellular	B-DNA
genes	I-DNA
is	O
considered	O
to	O
be	O
a	O
critical	O
event	O
in	O
T-cell	O
transformation	O
by	O
HTLV-I	O
.	O

To	O
elucidate	O
the	O
role	O
of	O
each	O
Tax1	B-protein
-inducible	O
transcriptional	O
pathway	O
in	O
T-cell	O
transformation	O
,	O
we	O
introduced	O
Tax1	B-protein
mutants	I-protein
with	O
different	O
trans-activating	O
phenotypes	O
into	O
peripheral	B-cell_type
blood	I-cell_type
lymphocytes	I-cell_type
(	O
PBL	B-cell_type
)	O
by	O
retroviral	O
vectors	O
.	O

Analysis	O
of	O
these	O
PBLs	B-cell_type
revealed	O
that	O
activation	O
of	O
the	O
NF-kappaB	B-protein
pathway	O
is	O
sufficient	O
to	O
promote	O
the	O
growth	O
response	O
to	O
IL-2	B-protein
.	O

However	O
,	O
for	O
the	O
clonal	O
expansion	O
of	O
CD4+	B-cell_type
T-cells	I-cell_type
,	O
which	O
is	O
a	O
characteristic	O
result	O
of	O
HTLV-I	O
infection	O
,	O
activation	O
of	O
the	O
CREB/ATF	O
and	O
SRF	O
pathways	O
is	O
also	O
required	O
.	O

Oncogene	NULL
(	NULL
1997	NULL
)	NULL
14	NULL
,	NULL
2071-2078	NULL
©	NULL
1997	NULL
Stockton	NULL
Press	NULL
All	NULL
rights	NULL
reserved	NULL
0950-9232/97	NULL
$	NULL
12.00	NULL
Characterization	NULL
of	NULL
peripheral	NULL
blood	NULL
T-lymphocytes	NULL
transduced	NULL
with	NULL
HTLV-I	NULL
Tax	NULL
mutants	NULL
with	NULL
different	NULL
trans-activating	NULL
phenotypes	NULL
Tsuyoshi	NULL
Akagi	NULL
,	NULL
Hiroaki	NULL
Ono	NULL
,	NULL
Hiroshi	NULL
Nyunoya	NULL
and	NULL
Kunitada	NULL
Shimotohno	NULL
Virology	NULL
Division	NULL
,	NULL
National	NULL
Cancer	NULL
Center	NULL
Research	NULL
Institute	NULL
,	NULL
5-1-1	NULL
Tsukiji	NULL
,	NULL
Chuo-ku	NULL
,	NULL
Tokyo	NULL
104	NULL
,	NULL
Japan	NULL
Tax1	NULL
,	NULL
a	NULL
transcriptional	NULL
trans-activator	NULL
of	NULL
the	NULL
Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-D	NULL
,	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
many	NULL
cellular	NULL
genes	NULL
through	NULL
interaction	NULL
with	NULL
at	NULL
least	NULL
three	NULL
distinct	NULL
cellular	NULL
transcription	NULL
factors	NULL
;	NULL
CREB/ATF	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
SRF	NULL
.	NULL

This	NULL
Taxl-induced	NULL
activation	NULL
of	NULL
cellular	NULL
genes	NULL
is	NULL
considered	NULL
to	NULL
be	NULL
a	NULL
critical	NULL
event	NULL
in	NULL
T-cell	NULL
transformation	NULL
by	NULL
HTLV-I	NULL
.	NULL

To	NULL
elucidate	NULL
the	NULL
role	NULL
of	NULL
each	NULL
Tax1l-inducible	NULL
transcriptional	NULL
pathway	NULL
in	NULL
T-cell	NULL
transformation	NULL
,	NULL
we	NULL
introduced	NULL
Tax1l	NULL
mutants	NULL
with	NULL
different	NULL
trans-activating	NULL
phenotypes	NULL
into	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
by	NULL
retroviral	NULL
vectors	NULL
.	NULL

Analysis	NULL
of	NULL
these	NULL
PBLs	NULL
revealed	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
NF-xB	NULL
pathway	NULL
is	NULL
sufficient	NULL
to	NULL
promote	NULL
the	NULL
growth	NULL
response	NULL
to	NULL
IL-2	NULL
.	NULL

However	NULL
,	NULL
for	NULL
the	NULL
clonal	NULL
expansion	NULL
of	NULL
CD4+	NULL
T-cells	NULL
,	NULL
which	NULL
is	NULL
a	NULL
characteristic	NULL
result	NULL
of	NULL
HTLV-I	NULL
infection	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
CREB/ATF	NULL
and	NULL
SRF	NULL
pathways	NULL
is	NULL
also	NULL
required	NULL
.	NULL

Keywords	NULL
:	NULL
HTLV-I	NULL
;	NULL
Tax	NULL
;	NULL
CD4	NULL
;	NULL
CD8	NULL
;	NULL
NF-	NULL
«	NULL
B	NULL
;	NULL
CREB/	NULL
ATF	NULL
Introduction	NULL
Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
is	NULL
the	NULL
etiological	NULL
agent	NULL
of	NULL
Adult	NULL
T-cell	NULL
leukemia	NULL
(	NULL
ATL	NULL
)	NULL
,	NULL
which	NULL
is	NULL
characterized	NULL
by	NULL
malignant	NULL
proliferation	NULL
of	NULL
CD4+	NULL
T-cells	NULL
,	NULL
and	NULL
this	NULL
virus	NULL
has	NULL
the	NULL
ability	NULL
to	NULL
transform	NULL
normal	NULL
T-cells	NULL
in	NULL
vitro	NULL
(	NULL
Feuer	NULL
and	NULL
Chen	NULL
,	NULL
1992	NULL
;	NULL
Hollsberg	NULL
and	NULL
Hafler	NULL
,	NULL
1993	NULL
;	NULL
Franchini	NULL
,	NULL
1995	NULL
;	NULL
Hollsberg	NULL
and	NULL
Hafler	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Taxl	NULL
,	NULL
a	NULL
transcriptional	NULL
trans-activator	NULL
of	NULL
this	NULL
virus	NULL
,	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
this	NULL
process	NULL
(	NULL
Franchini	NULL
,	NULL
1995	NULL
;	NULL
Yoshida	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Primary	NULL
human	NULL
T-cells	NULL
can	NULL
be	NULL
immortalized	NULL
by	NULL
Tax1	NULL
,	NULL
and	NULL
these	NULL
Tax1-immortalized	NULL
T-cells	NULL
exhibited	NULL
many	NULL
features	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
HTLV-I-transformed	NULL
T-cells	NULL
(	NULL
Akagi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995b	NULL
;	NULL
Akagi	NULL
and	NULL
Shimotohno	NULL
,	NULL
1993	NULL
;	NULL
Grassmann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Taxl	NULL
transcriptionally	NULL
activates	NULL
not	NULL
only	NULL
its	NULL
own	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
but	NULL
also	NULL
many	NULL
kinds	NULL
of	NULL
cellular	NULL
genes	NULL
,	NULL
including	NULL
the	NULL
immediate	NULL
early	NULL
serum	NULL
responsive	NULL
genes	NULL
(	NULL
c-fos	NULL
,	NULL
c-jun	NULL
,	NULL
egr-1	NULL
etc	NULL
.	NULL
)	NULL

,	NULL
cytokines	NULL
and	NULL
cytokine	NULL
receptor	NULL
genes	NULL
(	NULL
IL-2	NULL
,	NULL
IL-6	NULL
,	NULL
GM-CSF	NULL
,	NULL
TGF-f1	NULL
,	NULL
IL-2R4	NULL
,	NULL
IL-2Ry	NULL
etc	NULL
.	NULL
)	NULL

,	NULL
and	NULL
cell	NULL
adhesion	NULL
molecule	NULL
genes	NULL
(	NULL
JCAM-I	NULL
,	NULL
OX40	NULL
,	NULL
gp35	NULL
,	NULL
L-selectin	NULL
etc	NULL
.	NULL
)	NULL

(	NULL
Higashimura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Mori	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994a	NULL
;	NULL
Ohbo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Tatewaki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Yoshida	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
also	NULL
been	NULL
suggested	NULL
that	NULL
Tax1	NULL
can	NULL
modulate	NULL
the	NULL
expression	NULL
and	NULL
function	NULL
of	NULL
several	NULL
cell-cycle	NULL
regulatory	NULL
genes	NULL
(	NULL
Akagi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Cereseto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Suzuki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Correspondence	NULL
:	NULL
K	NULL
Shimotohno	NULL
Received	NULL
22	NULL
November	NULL
1996	NULL
;	NULL
revised	NULL
15	NULL
January	NULL
1997	NULL
;	NULL
accepted	NULL
16	NULL
January	NULL
1997	NULL
Previous	NULL
studies	NULL
on	NULL
the	NULL
mechanisms	NULL
of	NULL
Tax1-induced	NULL
transcriptional	NULL
activation	NULL
revealed	NULL
that	NULL
Taxl	NULL
can	NULL
interact	NULL
with	NULL
at	NULL
least	NULL
three	NULL
distinct	NULL
cellular	NULL
transcription	NULL
factors	NULL
;	NULL
CREB/ATF	NULL
,	NULL
NF-	NULL
«	NULL
xB	NULL
,	NULL
and	NULL
SRF	NULL
(	NULL
Yoshida	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Through	NULL
these	NULL
transcriptional	NULL
pathways	NULL
,	NULL
Taxl	NULL
activates	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cellular	NULL
genes	NULL
,	NULL
and	NULL
this	NULL
is	NULL
thought	NULL
to	NULL
mediate	NULL
T-cell	NULL
transformation	NULL
by	NULL
HTLV-I	NULL
.	NULL

The	NULL
role	NULL
of	NULL
each	NULL
Taxl-inducible	NULL
transcriptional	NULL
pathway	NULL
in	NULL
cell	NULL
transformation	NULL
has	NULL
been	NULL
studied	NULL
in	NULL
rodent	NULL
fibroblasts	NULL
(	NULL
Smith	NULL
and	NULL
Greene	NULL
,	NULL
1991	NULL
;	NULL
Yamaoka	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
however	NULL
it	NULL
remains	NULL
completely	NULL
unknown	NULL
in	NULL
T-cells	NULL
,	NULL
the	NULL
natural	NULL
target	NULL
of	NULL
HTLV-I	NULL
.	NULL

To	NULL
address	NULL
this	NULL
issue	NULL
,	NULL
we	NULL
introduced	NULL
several	NULL
Taxl	NULL
mutants	NULL
with	NULL
different	NULL
trans-activating	NULL
phenotypes	NULL
into	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
using	NULL
retroviral	NULL
vectors	NULL
,	NULL
and	NULL
analysed	NULL
the	NULL
phenotypes	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

We	NULL
demonstrate	NULL
under	NULL
these	NULL
conditions	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
NF-xB	NULL
pathway	NULL
is	NULL
sufficient	NULL
for	NULL
promoting	NULL
a	NULL
growth	NULL
response	NULL
to	NULL
IL-2	NULL
,	NULL
but	NULL
activation	NULL
of	NULL
the	NULL
CREB/	NULL
ATF	NULL
and	NULL
SRF	NULL
pathways	NULL
are	NULL
also	NULL
required	NULL
for	NULL
the	NULL
clonal	NULL
expansion	NULL
of	NULL
CD4+	NULL
T-cells	NULL
which	NULL
is	NULL
characteristically	NULL
observed	NULL
in	NULL
PBL	NULL
following	NULL
infection	NULL
with	NULL
HTLV-I	NULL
.	NULL

Results	NULL
Trans-activating	NULL
phenotypes	NULL
of	NULL
Tax1	NULL
mutants	NULL
To	NULL
elucidate	NULL
the	NULL
role	NULL
of	NULL
each	NULL
transcriptional	NULL
pathway	NULL
activated	NULL
by	NULL
Tax1	NULL
in	NULL
T-cell	NULL
transformation	NULL
,	NULL
three	NULL
Taxl	NULL
mutants	NULL
with	NULL
different	NULL
trans-activating	NULL
phenotypes	NULL
were	NULL
examined	NULL
in	NULL
comparison	NULL
with	NULL
wild-type	NULL
Taxl	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

Mutant	NULL
410	NULL
has	NULL
an	NULL
amino	NULL
acid	NULL
substitution	NULL
at	NULL
codons	NULL
310	NULL
and	NULL
311	NULL
from	NULL
Glu-Glu	NULL
to	NULL
Ala-Ser	NULL
,	NULL
which	NULL
is	NULL
equivalent	NULL
to	NULL
mutant	NULL
M44	NULL
designated	NULL
by	NULL
Smith	NULL
and	NULL
Greene	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Mutant	NULL
703	NULL
has	NULL
an	NULL
amino	NULL
acid	NULL
substitution	NULL
at	NULL
codons	NULL
319	NULL
and	NULL
320	NULL
from	NULL
Leu-Leu	NULL
to	NULL
Arg-Ser	NULL
,	NULL
which	NULL
is	NULL
equivalent	NULL
to	NULL
mutant	NULL
M47	NULL
(	NULL
Smith	NULL
and	NULL
Greene	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Mutant	NULL
M22	NULL
has	NULL
an	NULL
amino	NULL
acid	NULL
substitution	NULL
at	NULL
codons	NULL
130	NULL
and	NULL
131	NULL
from	NULL
Thr-Leu	NULL
to	NULL
Ser-Ala	NULL
(	NULL
Smith	NULL
and	NULL
Greene	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
Tax1l	NULL
mutants	NULL
and	NULL
wild-type	NULL
Tax1	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
bicistronic	NULL
retroviral	NULL
vector	NULL
LXEN	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
trans-activating	NULL
phenotypes	NULL
,	NULL
MOLT-4	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
plasmid	NULL
form	NULL
of	NULL
each	NULL
Taxl	NULL
expression	NULL
vector	NULL
and	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
.	NULL

The	NULL
vectors	NULL
p21x5-Luc	NULL
,	NULL
pCArG-Luc	NULL
,	NULL
pIL2R-Luc	NULL
were	NULL
used	NULL
as	NULL
the	NULL
reporters	NULL
for	NULL
the	NULL
CREB/	NULL
ATF	NULL
pathway	NULL
,	NULL
SRF	NULL
pathway	NULL
,	NULL
and	NULL
NF-xB	NULL
pathway	NULL
,	NULL
respectively	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
wild-type	NULL
Tax1	NULL
activated	NULL
all	NULL
the	NULL
three	NULL
pathways	NULL
.	NULL

Mutant	NULL
410	NULL
could	NULL
not	NULL
activate	NULL
any	NULL
of	NULL
these	NULL
pathways	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
results	NULL
with	NULL
mutant	NULL
M44	NULL
(	NULL
Smith	NULL
and	NULL
Greene	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Mutant	NULL
703	NULL
activated	NULL
the	NULL
NF-xB	NULL
pathway	NULL
but	NULL
failed	NULL
to	NULL
activate	NULL
the	NULL
CREB/ATF	NULL
and	NULL
SRF	NULL
pathways	NULL
,	NULL
which	NULL
is	NULL
PBL	NULL
transduced	NULL
with	NULL
HTLV-I	NULL
Tax	NULL
mutants	NULL
T	NULL
Akagi	NULL
et	NULL
al	NULL
2072	NULL
410	NULL
AS	NULL
703	NULL
mz	NULL
sa	NULL
(	NULL
B	NULL
)	NULL
LXEN	NULL
:	NULL
Bicistronic	NULL
retroviral	NULL
vector	NULL
Sac	NULL
I	NULL
Sac	NULL
I	NULL
Ecol	NULL
?	NULL

1	NULL
1	NULL
[	NULL
1	NULL
1	NULL
i	NULL
U	NULL
1	NULL
I	NULL
U	NULL
Aa	NULL
p21x5-Luc	NULL
RLU	NULL
x	NULL
104	NULL
m	NULL
-	NULL
t	NULL
wa	NULL
M	NULL
pCArG-Luc	NULL
Luciferase	NULL
activity	NULL
RLU	NULL
x	NULL
104	NULL
PJ	NULL
}	NULL
plL2R-Luc	NULL
RLU	NULL
x	NULL
104	NULL
&	NULL
&	NULL
}	NULL
N	NULL
No	NULL
1	NULL
Fi	NULL
l	NULL
I	NULL
LXEN	NULL
-	NULL
WT	NULL
410	NULL
703	NULL
M22	NULL
Figure	NULL
1	NULL
-	NULL
Tax1	NULL
mutants	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
structures	NULL
of	NULL
wild-type	NULL
Tax1	NULL
and	NULL
its	NULL
mutants	NULL
.	NULL

The	NULL
position	NULL
and	NULL
nature	NULL
of	NULL
amino	NULL
acid	NULL
substitutions	NULL
in	NULL
each	NULL
mutant	NULL
Tax1	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Schematic	NULL
structure	NULL
of	NULL
the	NULL
bicistronic	NULL
retroviral	NULL
vector	NULL
,	NULL
LXEN	NULL
,	NULL
used	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
Taxl	NULL
.	NULL

Symbols	NULL
:	NULL
LTR	NULL
:	NULL
long	NULL
terminal	NULL
repeat	NULL
;	NULL
¥+	NULL
,	NULL
extended	NULL
retroviral	NULL
packaging	NULL
signal	NULL
;	NULL
IRES	NULL
,	NULL
internal	NULL
ribosomal	NULL
entry	NULL
site	NULL
from	NULL
EMCV	NULL
;	NULL
neo	NULL
,	NULL
neomycin	NULL
resistance	NULL
gene	NULL
(	NULL
confers	NULL
resistance	NULL
to	NULL
G418	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Trans-activating	NULL
functions	NULL
of	NULL
each	NULL
mutant	NULL
Taxl	NULL
.	NULL

Two	NULL
ug	NULL
of	NULL
each	NULL
mutant	NULL
Taxl	NULL
cloned	NULL
in	NULL
the	NULL
plasmid	NULL
form	NULL
of	NULL
LXEN	NULL
were	NULL
co-transfected	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
p21x5-Luc	NULL
(	NULL
upper	NULL
)	NULL
,	NULL
pCArG-Luc	NULL
(	NULL
middle	NULL
)	NULL
,	NULL
or	NULL
pNFxBx4-Luc	NULL
(	NULL
lower	NULL
)	NULL
,	NULL
into	NULL
MOLT-4	NULL
cells	NULL
and	NULL
luciferase	NULL
activities	NULL
were	NULL
measured	NULL
.	NULL

RLU	NULL
,	NULL
relative	NULL
light	NULL
units	NULL
again	NULL
consistent	NULL
with	NULL
previous	NULL
results	NULL
with	NULL
mutant	NULL
M47	NULL
(	NULL
Smith	NULL
and	NULL
Greene	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
mutant	NULL
M22	NULL
could	NULL
not	NULL
activate	NULL
the	NULL
NF-xB	NULL
pathway	NULL
but	NULL
retained	NULL
the	NULL
ability	NULL
to	NULL
activate	NULL
the	NULL
CREB/ATF	NULL
and	NULL
SRF	NULL
pathways	NULL
.	NULL

Introduction	NULL
of	NULL
Tax1l	NULL
mutants	NULL
into	NULL
PBL	NULL
Helper-free	NULL
retroviral	NULL
stocks	NULL
of	NULL
each	NULL
mutant	NULL
and	NULL
wild-type	NULL
Taxl	NULL
were	NULL
prepared	NULL
using	NULL
PG13	NULL
packaging	NULL
cells	NULL
.	NULL

Primary	NULL
human	NULL
T-cells	NULL
derived	NULL
from	NULL
PBL	NULL
were	NULL
infected	NULL
with	NULL
these	NULL
retroviral	NULL
vectors	NULL
and	NULL
selected	NULL
with	NULL
G418	NULL
.	NULL

The	NULL
selection	NULL
efficiencies	NULL
did	NULL
not	NULL
differ	NULL
significantly	NULL
between	NULL
the	NULL
Taxl-expressing	NULL
retroviral	NULL
vectors	NULL
,	NULL
and	NULL
were	NULL
about	NULL
10	NULL
%	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
we	NULL
also	NULL
prepared	NULL
cells	NULL
infected	NULL
with	NULL
a	NULL
backbone	NULL
vector	NULL
LXEN	NULL
.	NULL

All	NULL
the	NULL
infected	NULL
PBLs	NULL
were	NULL
maintained	NULL
in	NULL
medium	NULL
containing	NULL
IL-2	NULL
.	NULL

After	NULL
one	NULL
month	NULL
culture	NULL
in	NULL
the	NULL
selection	NULL
medium	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
Tax1l	NULL
protein	NULL
in	NULL
these	NULL
PBLs	NULL
was	NULL
examined	NULL
.	NULL

The	NULL
40	NULL
kDa	NULL
Tax1	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
all	NULL
the	NULL
Taxl-transduced	NULL
PBL	NULL
by	NULL
immunoblot	NULL
analysis	NULL
,	NULL
although	NULL
levels	NULL
of	NULL
expression	NULL
were	NULL
somewhat	NULL
different	NULL
(	NULL
Figure	NULL
2a	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
characteristic	NULL
trans-activating	NULL
properties	NULL
of	NULL
each	NULL
Tax1	NULL
mutants	NULL
,	NULL
which	NULL
were	NULL
demonstrated	NULL
in	NULL
MOLT-4	NULL
cells	NULL
by	NULL
transient	NULL
expression	NULL
experiments	NULL
,	NULL
could	NULL
also	NULL
be	NULL
observed	NULL
in	NULL
each	NULL
retroviral	NULL
vector	NULL
infected	NULL
PBL	NULL
,	NULL
the	NULL
activities	NULL
of	NULL
each	NULL
Tax1-responsive	NULL
promoter	NULL
were	NULL
assayed	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
the	NULL
pNFxBx4-Luc	NULL
vector	NULL
which	NULL
has	NULL
4	NULL
copies	NULL
of	NULL
the	NULL
NF-xB	NULL
site	NULL
was	NULL
used	NULL
as	NULL
a	NULL
reporter	NULL
for	NULL
the	NULL
NF-xB	NULL
pathway	NULL
instead	NULL
of	NULL
pIL2R-Luc	NULL
,	NULL
to	NULL
increase	NULL
the	NULL
sensitivity	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
2b	NULL
,	NULL
all	NULL
three	NULL
pathways	NULL
were	NULL
activated	NULL
in	NULL
PBL	NULL
expressing	NULL
wild-type	NULL
Tax1	NULL
,	NULL
and	NULL
none	NULL
were	NULL
significantly	NULL
activated	NULL
in	NULL
PBL	NULL
expressing	NULL
Tax1	NULL
mutant	NULL
410	NULL
.	NULL

In	NULL
PBL	NULL
expressing	NULL
Taxl	NULL
mutant	NULL
703	NULL
,	NULL
only	NULL
the	NULL
NF-xB	NULL
pathway	NULL
was	NULL
activated	NULL
.	NULL

And	NULL
in	NULL
PBL	NULL
expressing	NULL
mutant	NULL
M22	NULL
,	NULL
the	NULL
CREB/ATF	NULL
and	NULL
SRF	NULL
pathways	NULL
,	NULL
but	NULL
not	NULL
the	NULL
NF-xB	NULL
pathway	NULL
,	NULL
were	NULL
activated	NULL
.	NULL

Thus	NULL
the	NULL
expression	NULL
of	NULL
each	NULL
mutant	NULL
Taxl	NULL
with	NULL
the	NULL
predicted	NULL
phenotypes	NULL
was	NULL
confirmed	NULL
in	NULL
each	NULL
retroviral	NULL
vector	NULL
infected	NULL
PBL	NULL
.	NULL

Characterization	NULL
of	NULL
each	NULL
Tax1	NULL
mutant	NULL
transduced	NULL
PBL	NULL
s	NULL
The	NULL
growth	NULL
properties	NULL
of	NULL
the	NULL
infected	NULL
PBLs	NULL
were	NULL
examined	NULL
at	NULL
about	NULL
1	NULL
month	NULL
post-infection	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Each	NULL
retroviral	NULL
vector	NULL
infected	NULL
PBLs	NULL
were	NULL
cultured	NULL
with	NULL
relatively	NULL
low	NULL
levels	NULL
of	NULL
IL-2	NULL
(	NULL
10	NULL
u/ml	NULL
)	NULL
in	NULL
the	NULL
medium	NULL
,	NULL
and	NULL
cell	NULL
proliferation	NULL
was	NULL
assayed	NULL
by	NULL
the	NULL
MTS	NULL
colorimetric	NULL
method	NULL
.	NULL

When	NULL
compared	NULL
to	NULL
control	NULL
vector	NULL
LXEN	NULL
infected	NULL
PBL	NULL
,	NULL
PBLs	NULL
infected	NULL
with	NULL
mutant	NULL
703	NULL
and	NULL
wild-type	NULL
Taxl	NULL
showed	NULL
markedly	NULL
higher	NULL
proliferative	NULL
responses	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
PBLs	NULL
expressing	NULL
mutant	NULL
410	NULL
and	NULL
mutant	NULL
M22	NULL
proliferated	NULL
at	NULL
similar	NULL
or	NULL
even	NULL
lower	NULL
levels	NULL
than	NULL
control	NULL
PBL	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
show	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
NF-xB	NULL
pathway	NULL
is	NULL
critical	NULL
in	NULL
promoting	NULL
the	NULL
growth	NULL
response	NULL
to	NULL
IL-2	NULL
.	NULL

At	NULL
this	NULL
time	NULL
point	NULL
,	NULL
the	NULL
cell-surface	NULL
expression	NULL
of	NULL
CD4	NULL
,	NULL
CD8	NULL
,	NULL
and	NULL
CD25	NULL
(	NULL
IL-2Ra	NULL
)	NULL
antigens	NULL
were	NULL
analysed	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
over	NULL
90	NULL
%	NULL
of	NULL
cells	NULL
were	NULL
CD8+	NULL
and	NULL
less	NULL
than	NULL
10	NULL
%	NULL
of	NULL
cells	NULL
were	NULL
CD4+	NULL
.	NULL

Since	NULL
the	NULL
initial	NULL
surface	NULL
phenotypes	NULL
of	NULL
PBL	NULL
used	NULL
for	NULL
the	NULL
infection	NULL
experiment	NULL
were	NULL
30	NULL
%	NULL
CD4+	NULL
and	NULL
70	NULL
%	NULL
CD8	NULL
+	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
CD8	NULL
+	NULL
cells	NULL
grew	NULL
preferentially	NULL
during	NULL
1	NULL
month	NULL
culture	NULL
.	NULL

This	NULL
also	NULL
happened	NULL
in	NULL
uninfected	NULL
PBL	NULL
maintained	NULL
for	NULL
the	NULL
same	NULL
period	NULL
,	NULL
and	NULL
such	NULL
phenomena	NULL
have	NULL
been	NULL
well	NULL
documented	NULL
previously	NULL
(	NULL
Gullberg	NULL
and	NULL
Smith	NULL
,	NULL
1986	NULL
)	NULL
.	NULL

Only	NULL
in	NULL
wild-type	NULL
and	NULL
mutant	NULL
703	NULL
expressing	NULL
PBLs	NULL
small	NULL
but	NULL
significant	NULL
populations	NULL
of	NULL
cells	NULL
(	NULL
10-20	NULL
%	NULL
)	NULL
were	NULL
strongly	NULL
positive	NULL
for	NULL
CD25	NULL
(	NULL
IL-2Ra	NULL
)	NULL
,	NULL
while	NULL
any	NULL
other	NULL
a	NULL
hel	NULL
6	NULL
2	NULL
o	NULL
6	NULL
Wa	NULL
i	NULL
o	NULL
o	NULL
A	NULL
>	NULL
¢	NULL
hire	NULL
O	NULL
2	NULL
t	NULL
s	NULL
3	NULL
20	NULL
so	NULL
500	NULL
%	NULL
50	NULL
5	NULL
2	NULL
m	NULL
m	NULL
m	NULL
m	NULL
fam	NULL
)	NULL
3	NULL
a.	NULL
a.	NULL
a.	NULL
a.	NULL
a	NULL
.	NULL

``	NULL
3	NULL
«	NULL
mee	NULL
_	NULL
--	NULL
——-	NULL
<	NULL
a	NULL
pAQ	NULL
AX	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Blot	NULL
:	NULL
TAXY	NULL
7	NULL
(	NULL
anti-Tax	NULL
mAb	NULL
)	NULL
b	NULL
80	NULL
7	NULL
®	NULL
p21x5-Lue	NULL
40	NULL
4	NULL
20	NULL
4	NULL
pCArG-Luc	NULL
pNFxBx4-Luc	NULL
Relative	NULL
Luciferase	NULL
activity	NULL
(	NULL
%	NULL
of	NULL
pCMV-Luc	NULL
)	NULL
”	NULL
Jav-oj	NULL
$	NULL
ig	NULL
220.112	NULL
Figure	NULL
2	NULL
Expression	NULL
of	NULL
each	NULL
Taxl	NULL
mutant	NULL
in	NULL
PBL	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Immunoblot	NULL
analysis	NULL
of	NULL
Taxl	NULL
protein	NULL
.	NULL

Whole	NULL
cell	NULL
lysate	NULL
derived	NULL
from	NULL
5x	NULL
10°	NULL
cells	NULL
of	NULL
each	NULL
PBL	NULL
was	NULL
subjected	NULL
to	NULL
immunoblot	NULL
analysis	NULL
with	NULL
mouse	NULL
anti-Tax	NULL
monoclonal	NULL
antibody	NULL
TAXY7	NULL
.	NULL

The	NULL
band	NULL
for	NULL
p40	NULL
``	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

Bands	NULL
at	NULL
slightly	NULL
higher	NULL
molecular	NULL
weight	NULL
than	NULL
40	NULL
kDa	NULL
were	NULL
non-specific	NULL
,	NULL
because	NULL
they	NULL
were	NULL
detected	NULL
both	NULL
in	NULL
uninfected	NULL
PBL	NULL
and	NULL
LXEN	NULL
infected	NULL
PBL	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
uninfected	NULL
PBL	NULL
;	NULL
2	NULL
,	NULL
PBL/LXEN	NULL
,	NULL
PBL	NULL
infected	NULL
with	NULL
control	NULL
vector	NULL
LXEN	NULL
;	NULL
3	NULL
,	NULL
PBL/WT	NULL
,	NULL
PBL	NULL
infected	NULL
with	NULL
wild-type	NULL
Taxl	NULL
expressing	NULL
vector	NULL
LTEN	NULL
(	NULL
WT	NULL
)	NULL
;	NULL
4	NULL
,	NULL
PBL/410	NULL
,	NULL
PBL	NULL
infected	NULL
with	NULL
mutant	NULL
410	NULL
expressing	NULL
vector	NULL
LTEN	NULL
(	NULL
410	NULL
)	NULL
;	NULL
5	NULL
,	NULL
PBL/703	NULL
,	NULL
PBL	NULL
infected	NULL
with	NULL
mutant	NULL
703	NULL
expressing	NULL
vector	NULL
LTEN	NULL
(	NULL
703	NULL
)	NULL
;	NULL
6	NULL
,	NULL
PBL/	NULL
M22	NULL
,	NULL
PBL	NULL
infected	NULL
with	NULL
mutant	NULL
M22	NULL
expressing	NULL
vector	NULL
LTEN	NULL
(	NULL
M22	NULL
)	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Assay	NULL
of	NULL
Taxl-responsive	NULL
promoter	NULL
activity	NULL
.	NULL

PBLs	NULL
infected	NULL
with	NULL
each	NULL
retroviral	NULL
vector	NULL
were	NULL
electroporated	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
p21x5-Luc	NULL
(	NULL
upper	NULL
)	NULL
,	NULL
pCArG-Luc	NULL
(	NULL
middle	NULL
)	NULL
,	NULL
pNFxBx4-Luc	NULL
{	NULL
lower	NULL
)	NULL
,	NULL
or	NULL
pCMV-Luc	NULL
,	NULL
and	NULL
luciferase	NULL
activities	NULL
were	NULL
measured	NULL
.	NULL

To	NULL
normalize	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
electroporation	NULL
efficiencies	NULL
between	NULL
each	NULL
PBL	NULL
,	NULL
the	NULL
values	NULL
are	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
pCMV-Lue	NULL
which	NULL
is	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
Taxl	NULL
in	NULL
PBL	NULL
(	NULL
Akagi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
PBL	NULL
transduced	NULL
with	NULL
HTLV-I	NULL
Tax	NULL
mutants	NULL
T	NULL
Akagi	NULL
et	NULL
al	NULL
-	NULL
@	NULL
-	NULL
PBLMT	NULL
-O-	NULL
PBL/410	NULL
-B-	NULL
PBL/703	NULL
-	NULL
[	NULL
_	NULL
}	NULL
-	NULL
PBL/MM22	NULL
MTS	NULL
(	NULL
A	NULL
480nm	NULL
)	NULL
Days	NULL
of	NULL
culture	NULL
in	NULL
IL-2	NULL
(	NULL
10	NULL
u/mi	NULL
)	NULL
Figure	NULL
3	NULL
-	NULL
Growth	NULL
response	NULL
to	NULL
IL-2	NULL
of	NULL
PBLs	NULL
expressing	NULL
each	NULL
Taxl	NULL
mutant	NULL
.	NULL

PBLs	NULL
infected	NULL
with	NULL
each	NULL
retroviral	NULL
vector	NULL
were	NULL
maintained	NULL
in	NULL
PBL-medium	NULL
(	NULL
200	NULL
u/ml	NULL
IL-2	NULL
)	NULL
for	NULL
about	NULL
a	NULL
month	NULL
post-infection	NULL
,	NULL
and	NULL
were	NULL
then	NULL
cultured	NULL
in	NULL
medium	NULL
lacking	NULL
IL-2	NULL
for	NULL
24	NULL
h	NULL
in	NULL
flat	NULL
bottom	NULL
96	NULL
well	NULL
plates	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
well	NULL
)	NULL
,	NULL
and	NULL
then	NULL
IL-2	NULL
was	NULL
added	NULL
to	NULL
each	NULL
well	NULL
at	NULL
10	NULL
u/ml	NULL
.	NULL

Cell	NULL
proliferations	NULL
were	NULL
assayed	NULL
just	NULL
prior	NULL
to	NULL
,	NULL
and	NULL
at	NULL
3	NULL
and	NULL
6	NULL
days	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
IL-2	NULL
by	NULL
MTS	NULL
colorimetric	NULL
method	NULL
,	NULL
and	NULL
were	NULL
shown	NULL
as	NULL
absorbance	NULL
(	NULL
at	NULL
490	NULL
nm	NULL
)	NULL
values	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
averages	NULL
of	NULL
triplicates	NULL
CD4	NULL
CDs	NULL
CD25	NULL
(	NULL
IL2Ra	NULL
)	NULL
96	NULL
4	NULL
96	NULL
4	NULL
96-	NULL
#	NULL
44	NULL
644	NULL
s-PBL/WT	NULL
ar	NULL
824	NULL
224	NULL
i	NULL
o	NULL
ds	NULL
-	NULL
ds	NULL
°	NULL
0	NULL
aa	NULL
Gs	NULL
|	NULL
or	NULL
300	NULL
a	NULL
o	NULL
oan	NULL
|	NULL
as	NULL
96	NULL
4	NULL
96	NULL
4	NULL
%	NULL
4	NULL
g44	NULL
644	NULL
64-4	NULL
PBL/410	NULL
32-	NULL
l	NULL
32-	NULL
324	NULL
*	NULL
e	NULL
o	NULL
ars	NULL
0	NULL
ase	NULL
O	NULL
a	NULL
o	NULL
das	NULL
0	NULL
ase	NULL
°	NULL
ea	NULL
dre	NULL
0	NULL
nse	NULL
064	NULL
96	NULL
96	NULL
644	NULL
64	NULL
4	NULL
sa-PBL/703	NULL
C	NULL
224	NULL
'	NULL
ar-	NULL
l	NULL
0	NULL
a	NULL
0	NULL
dre	NULL
0	NULL
daa	NULL
9	NULL
ec	NULL
00	NULL
dog	NULL
0	NULL
492	NULL
0	NULL
aa	NULL
0	NULL
drB	NULL
0	NULL
do	NULL
?	NULL

96	NULL
4	NULL
961	NULL
96-64-	NULL
644	NULL
64-4	NULL
PBL/M22	NULL
a24	NULL
a24	NULL
22	NULL
I	NULL
0	NULL
e	NULL
ar	NULL
0	NULL
age	NULL
C	NULL
ea	NULL
0	NULL
128	NULL
1s	NULL
°	NULL
ea	NULL
0	NULL
drs	NULL
0	NULL
192	NULL
96	NULL
4	NULL
96	NULL
4	NULL
96W	NULL
644	NULL
644	NULL
04-4	NULL
PBL/LXEN	NULL
324	NULL
325	NULL
824	NULL
0	NULL
a	NULL
0	NULL
es	NULL
0	NULL
128	NULL
182	NULL
ea	NULL
0	NULL
drs	NULL
00	NULL
dor	NULL
ea	NULL
0	NULL
dag	NULL
0	NULL
doz	NULL
964	NULL
964	NULL
96-un-	NULL
6a	NULL
ea	NULL
4	NULL
sa-infected	NULL
324	NULL
324	NULL
32-4	NULL
0	NULL
64	NULL
128	NULL
192	NULL
°	NULL
64	NULL
fre	NULL
ase	NULL
9	NULL
64	NULL
128	NULL
192	NULL
Figure	NULL
4	NULL
Cell-surface	NULL
phenotypes	NULL
of	NULL
PBLs	NULL
expressing	NULL
each	NULL
Taxl	NULL
mutant	NULL
.	NULL

PBLs	NULL
infected	NULL
with	NULL
each	NULL
retroviral	NULL
vector	NULL
as	NULL
well	NULL
as	NULL
uninfected	NULL
PBL	NULL
maintained	NULL
in	NULL
PBL-medium	NULL
(	NULL
200	NULL
u/ml	NULL
IL-2	NULL
)	NULL
for	NULL
about	NULL
a	NULL
month	NULL
were	NULL
subjected	NULL
to	NULL
FACS	NULL
analysis	NULL
.	NULL

Cytofluorometric	NULL
profiles	NULL
of	NULL
cells	NULL
stained	NULL
with	NULL
anti-CD4	NULL
antibody	NULL
,	NULL
anti-CD8	NULL
antibody	NULL
,	NULL
or	NULL
anti-CD25	NULL
antibody	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
vertical	NULL
axis	NULL
indicates	NULL
relative	NULL
cell	NULL
numbers	NULL
,	NULL
and	NULL
the	NULL
horizontal	NULL
axis	NULL
indicates	NULL
relative	NULL
fluorescence	NULL
intensities	NULL
.	NULL

We	NULL
confirmed	NULL
that	NULL
the	NULL
fluorescence	NULL
intensity	NULL
of	NULL
the	NULL
staining	NULL
with	NULL
the	NULL
negative	NULL
control	NULL
antibody	NULL
,	NULL
FITC-conjugated	NULL
normal	NULL
mouse	NULL
IgG	NULL
,	NULL
was	NULL
less	NULL
than	NULL
64	NULL
in	NULL
each	NULL
case	NULL
-	NULL
&	NULL
-	NULL
PBL/LXEN	NULL
2073	NULL
PBL	NULL
transduced	NULL
with	NULL
HTLV-I	NULL
Tax	NULL
mutants	NULL
T	NULL
Akagi	NULL
et	NULL
al	NULL
2074	NULL
PBLs	NULL
were	NULL
almost	NULL
negative	NULL
.	NULL

The	NULL
existence	NULL
of	NULL
these	NULL
CD25	NULL
positive	NULL
cells	NULL
probably	NULL
explain	NULL
the	NULL
high	NULL
responsiveness	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
IL-2	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
Taxl	NULL
promotes	NULL
growth	NULL
response	NULL
to	NULL
IL-2	NULL
by	NULL
inducing	NULL
CD25	NULL
(	NULL
IL-2R	NULL
«	NULL
)	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-xB	NULL
pathway	NULL
.	NULL

Long-term	NULL
expansion	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
703	NULL
expressing	NULL
PBLs	NULL
Wild-type	NULL
and	NULL
mutant	NULL
703	NULL
expressing	NULL
PBLs	NULL
grew	NULL
at	NULL
a	NULL
constant	NULL
,	NULL
continuous	NULL
rate	NULL
,	NULL
and	NULL
were	NULL
easily	NULL
expanded	NULL
in	NULL
medium	NULL
containing	NULL
IL-2	NULL
over	NULL
a	NULL
longer	NULL
period	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
proliferation	NULL
rates	NULL
of	NULL
LXEN	NULL
,	NULL
mutant	NULL
410	NULL
,	NULL
and	NULL
mutant	NULL
M22	NULL
expressing	NULL
PBLs	NULL
declined	NULL
gradually	NULL
,	NULL
and	NULL
it	NULL
became	NULL
very	NULL
difficult	NULL
to	NULL
expand	NULL
them	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
.	NULL

Then	NULL
,	NULL
wild-type	NULL
and	NULL
mutant	NULL
703	NULL
expressing	NULL
PBLs	NULL
were	NULL
subjected	NULL
to	NULL
long-term	NULL
observa-tion	NULL
.	NULL

At	NULL
4	NULL
and	NULL
6	NULL
months	NULL
post-infection	NULL
,	NULL
cell	NULL
surface	NULL
phenotypes	NULL
were	NULL
analysed	NULL
by	NULL
FACS	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

In	NULL
wild-type	NULL
Tax1l	NULL
expressing	NULL
PBL	NULL
,	NULL
a	NULL
fraction	NULL
of	NULL
CD4+	NULL
cells	NULL
appeared	NULL
at	NULL
4	NULL
months	NULL
post-infection	NULL
(	NULL
about	NULL
30	NULL
%	NULL
)	NULL
,	NULL
and	NULL
became	NULL
dominant	NULL
(	NULL
over	NULL
90	NULL
%	NULL
)	NULL
at	NULL
6	NULL
months	NULL
post-infection	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutant	NULL
703	NULL
expressing	NULL
PBL	NULL
were	NULL
negative	NULL
for	NULL
CD4	NULL
even	NULL
at	NULL
6	NULL
months	NULL
post-infection	NULL
,	NULL
with	NULL
CD4	NULL
CD25	NULL
(	NULL
IL2Ra	NULL
)	NULL
96	NULL
as	NULL
64	NULL
64	NULL
4	NULL
m	NULL
P..	NULL
a2	NULL
a2	NULL
PBLAWT	NULL
U	NULL
s	NULL
00	NULL
rae	NULL
00	NULL
492	NULL
0	NULL
ea	NULL
0	NULL
dre	NULL
00	NULL
492	NULL
ss	NULL
as	NULL
a4	NULL
sa	NULL
6	NULL
m	NULL
P..	NULL
32	NULL
a2	NULL
0	NULL
64	NULL
128	NULL
192	NULL
0	NULL
s4	NULL
128	NULL
192	NULL
96	NULL
96	NULL
6a	NULL
ee	NULL
4	NULL
m	NULL
a2	NULL
a2	NULL
PBL/703	NULL
0	NULL
84	NULL
128	NULL
192	NULL
0	NULL
64	NULL
128	NULL
182	NULL
96	NULL
95	NULL
sa	NULL
64	NULL
6	NULL
m	NULL
P..	NULL
a2	NULL
a2	NULL
0	NULL
64	NULL
128	NULL
102	NULL
0	NULL
ea	NULL
0	NULL
128	NULL
192	NULL
Figure	NULL
5	NULL
Cell-surface	NULL
phenotypes	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
703	NULL
expressing	NULL
PBLs	NULL
after	NULL
long-term	NULL
culture	NULL
.	NULL

Wild-type	NULL
Taxl	NULL
expressing	NULL
PBL	NULL
(	NULL
upper	NULL
)	NULL
and	NULL
mutant	NULL
703	NULL
expressing	NULL
PBL	NULL
(	NULL
lower	NULL
)	NULL
,	NULL
which	NULL
were	NULL
maintained	NULL
in	NULL
PBL-medium	NULL
(	NULL
200	NULL
u/ml	NULL
IL-2	NULL
)	NULL
,	NULL
were	NULL
subjected	NULL
to	NULL
FACS	NULL
analysis	NULL
at	NULL
4	NULL
months	NULL
and	NULL
6	NULL
months	NULL
post-infection	NULL
(	NULL
4	NULL
m	NULL
P.I	NULL
.	NULL

and	NULL
6	NULL
m	NULL
P.1	NULL
.	NULL
)	NULL

.	NULL

Cytofluorometric	NULL
profiles	NULL
of	NULL
cells	NULL
stained	NULL
with	NULL
anti-CD4	NULL
antibody	NULL
,	NULL
or	NULL
anti-CD25	NULL
antibody	NULL
,	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
vertical	NULL
axis	NULL
indicates	NULL
relative	NULL
cell	NULL
numbers	NULL
,	NULL
and	NULL
the	NULL
horizontal	NULL
axis	NULL
indicates	NULL
relative	NULL
fluorescence	NULL
intensities	NULL
We	NULL
confirmed	NULL
that	NULL
the	NULL
fluorescence	NULL
intensity	NULL
of	NULL
the	NULL
staining	NULL
with	NULL
negative	NULL
control	NULL
antibody	NULL
,	NULL
FITC-conjugated	NULL
normal	NULL
mouse	NULL
IgG	NULL
,	NULL
was	NULL
less	NULL
than	NULL
64	NULL
in	NULL
each	NULL
case	NULL
over	NULL
90	NULL
%	NULL
of	NULL
these	NULL
cells	NULL
being	NULL
CD8	NULL
+	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
number	NULL
of	NULL
cells	NULL
strongly	NULL
positive	NULL
for	NULL
CD25	NULL
(	NULL
IL2Ra	NULL
)	NULL
expression	NULL
increased	NULL
in	NULL
culture	NULL
both	NULL
in	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
703	NULL
expressing	NULL
PBLs	NULL
.	NULL

Reflecting	NULL
these	NULL
augmented	NULL
expressions	NULL
of	NULL
CD25	NULL
(	NULL
IL-2Ra	NULL
)	NULL
,	NULL
both	NULL
PBLs	NULL
showed	NULL
vigorous	NULL
proliferative	NULL
responses	NULL
to	NULL
IL-2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Clonal	NULL
expansion	NULL
of	NULL
CD4+	NULL
cells	NULL
in	NULL
wild-type	NULL
Tax1	NULL
expressing	NULL
PBL	NULL
To	NULL
know	NULL
whether	NULL
the	NULL
marked	NULL
difference	NULL
in	NULL
the	NULL
emergence	NULL
of	NULL
CD4+	NULL
cells	NULL
in	NULL
wild-type	NULL
and	NULL
mutant	NULL
703	NULL
expressing	NULL
PBLs	NULL
was	NULL
observed	NULL
only	NULL
in	NULL
these	NULL
particular	NULL
cultures	NULL
or	NULL
not	NULL
,	NULL
other	NULL
cultures	NULL
of	NULL
both	NULL
PBLs	NULL
were	NULL
investigated	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

There	NULL
were	NULL
five	NULL
more	NULL
cultures	NULL
of	NULL
both	NULL
cell	NULL
types	NULL
showing	NULL
continuous	NULL
cell	NULL
growth	NULL
,	NULL
which	NULL
have	NULL
been	NULL
divided	NULL
into	NULL
separate	NULL
culture	NULL
wells	NULL
just	NULL
after	NULL
infection	NULL
and	NULL
maintained	NULL
independently	NULL
thereafter	NULL
for	NULL
more	NULL
than	NULL
8	NULL
months	NULL
.	NULL

In	NULL
four	NULL
out	NULL
of	NULL
five	NULL
cultures	NULL
of	NULL
wild-type	NULL
Tax1l	NULL
expressing	NULL
PBLs	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
proportion	NULL
of	NULL
CD4	NULL
+	NULL
cells	NULL
was	NULL
evident	NULL
and	NULL
the	NULL
majority	NULL
of	NULL
cells	NULL
(	NULL
70-95	NULL
%	NULL
)	NULL
were	NULL
CD4	NULL
positive	NULL
for	NULL
at	NULL
8	NULL
months	NULL
post-infection	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expansion	NULL
of	NULL
CD4+	NULL
cells	NULL
was	NULL
not	NULL
seen	NULL
in	NULL
any	NULL
of	NULL
the	NULL
five	NULL
cultures	NULL
of	NULL
the	NULL
PBL	NULL
transduced	NULL
with	NULL
mutant	NULL
703	NULL
even	NULL
at	NULL
8	NULL
months	NULL
post-infection	NULL
,	NULL
and	NULL
over	NULL
95	NULL
%	NULL
of	NULL
all	NULL
these	NULL
cultures	NULL
were	NULL
confirmed	NULL
to	NULL
be	NULL
CD8+	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
CD4+	NULL
cells	NULL
in	NULL
wild-type	NULL
Taxl	NULL
expressing	NULL
PBL	NULL
once	NULL
became	NULL
very	NULL
low	NULL
(	NULL
at	NULL
1	NULL
month	NULL
post-infection	NULL
)	NULL
and	NULL
then	NULL
gradually	NULL
increased	NULL
,	NULL
suggesting	NULL
that	NULL
clonal	NULL
expansion	NULL
of	NULL
the	NULL
initially	NULL
very	NULL
minor	NULL
population	NULL
of	NULL
CD4+	NULL
cells	NULL
took	NULL
place	NULL
during	NULL
the	NULL
long-term	NULL
culture	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
the	NULL
clonal	NULL
compositions	NULL
of	NULL
these	NULL
cells	NULL
were	NULL
examined	NULL
by	NULL
analysing	NULL
the	NULL
integration	NULL
sites	NULL
of	NULL
the	NULL
retroviral	NULL
vectors	NULL
by	NULL
Southern	NULL
blotting	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
Tax1	NULL
and	NULL
mutant	NULL
703	NULL
expressing	NULL
PBL	NULL
at	NULL
1	NULL
,	NULL
4	NULL
(	NULL
5	NULL
in	NULL
the	NULL
case	NULL
of	NULL
mutant	NULL
703	NULL
)	NULL
and	NULL
6	NULL
months	NULL
post-infection	NULL
,	NULL
and	NULL
other	NULL
five	NULL
separately	NULL
maintained	NULL
cultures	NULL
of	NULL
both	NULL
cell	NULL
types	NULL
were	NULL
examined	NULL
.	NULL

In	NULL
both	NULL
cell	NULL
types	NULL
,	NULL
at	NULL
1	NULL
month	NULL
post-infection	NULL
,	NULL
the	NULL
signals	NULL
were	NULL
smearing	NULL
,	NULL
indicating	NULL
that	NULL
Table	NULL
1	NULL
Percentages	NULL
of	NULL
CD4	NULL
positive	NULL
cells	NULL
in	NULL
wild-type	NULL
and	NULL
mutant	NULL
703	NULL
expressing	NULL
PBLs	NULL
CD4	NULL
positive	NULL
cell	NULL
rate	NULL
Well	NULL
No	NULL
.	NULL

3	NULL
m	NULL
PI	NULL
.	NULL

8	NULL
m	NULL
P1	NULL
.	NULL

PBL/WT	NULL
A-1	NULL
29.3	NULL
%	NULL
95	NULL
%	NULL
A-2	NULL
7.0	NULL
%	NULL
88.2	NULL
%	NULL
A-3	NULL
41.1	NULL
%	NULL
95.2	NULL
%	NULL
A-4	NULL
7.1	NULL
%	NULL
69.7	NULL
%	NULL
C-1	NULL
11.8	NULL
%	NULL
4.5	NULL
%	NULL
PBL/703	NULL
A-2	NULL
1.2	NULL
%	NULL
3.2	NULL
%	NULL
A-3	NULL
0.7	NULL
%	NULL
2.1	NULL
%	NULL
B-2	NULL
-	NULL
3.4	NULL
%	NULL
B-3	NULL
3.8	NULL
%	NULL
1.7	NULL
%	NULL
B-4	NULL
3.3	NULL
%	NULL
2.1	NULL
%	NULL
Five	NULL
individual	NULL
cultures	NULL
of	NULL
wild-type	NULL
expressing	NULL
PBL	NULL
(	NULL
upper	NULL
half	NULL
)	NULL
and	NULL
mutant	NULL
703	NULL
expressing	NULL
PBL	NULL
(	NULL
lower	NULL
half	NULL
)	NULL
were	NULL
analysed	NULL
for	NULL
CD4	NULL
positive	NULL
cells	NULL
at	NULL
3	NULL
and	NULL
8	NULL
month	NULL
post-infection	NULL
by	NULL
FACS	NULL
.	NULL

These	NULL
cultures	NULL
,	NULL
which	NULL
were	NULL
different	NULL
from	NULL
those	NULL
shown	NULL
in	NULL
Figure	NULL
5	NULL
,	NULL
were	NULL
divided	NULL
into	NULL
the	NULL
separate	NULL
culture	NULL
wells	NULL
just	NULL
after	NULL
infection	NULL
and	NULL
maintained	NULL
independently	NULL
thereafter	NULL
.	NULL

Cells	NULL
with	NULL
fluorescence	NULL
intensity	NULL
over	NULL
64	NULL
were	NULL
counted	NULL
as	NULL
positive	NULL
cells	NULL
PBL	NULL
transduced	NULL
with	NULL
HTLV-I	NULL
Tax	NULL
mutants	NULL
T	NULL
Akagi	NULL
et	NULL
al	NULL
2075	NULL
PBL/AWT	NULL
PBL/703	NULL
I	NULL
I	NULL
I	NULL
I	NULL
2	NULL
E	NULL
@	NULL
@	NULL
&	NULL
a	NULL
&	NULL
&	NULL
E	NULL
a	NULL
De	NULL
oe	NULL
e	NULL
y	NULL
e	NULL
Eo	NULL
E	NULL
OE	NULL
O6	NULL
gE	NULL
Cae	NULL
e	NULL
og	NULL
.	NULL

-	NULL
E	NULL
OE	NULL
OE	NULL
oE	NULL
-E	NULL
co	NULL
co	NULL
ro	NULL
#	NULL
0	NULL
#	NULL
0	NULL
s	NULL
0	NULL
co	NULL
ro	NULL
c	NULL
ob	NULL
B	NULL
oB	NULL
om	NULL
ob	NULL
E00	NULL
E	NULL
E	NULL
om	NULL
OM	NULL
9	NULL
°	NULL
%	NULL
or	NULL
E	NULL
E	NULL
E	NULL
f°	NULL
@	NULL
0°	NULL
wo	NULL
a	NULL
os	NULL
to	NULL
o	NULL
<	NULL
0	NULL
<	NULL
0	NULL
<	NULL
0	NULL
<	NULL
o	NULL
-o	NULL
m	NULL
oo	NULL
<	NULL
<	NULL
do	NULL
mo	NULL
m	NULL
12	NULL
kb	NULL
10	NULL
kb	NULL
-	NULL
|	NULL
8	NULL
kb	NULL
-	NULL
|	NULL
6	NULL
kb	NULL
-	NULL
|	NULL
5	NULL
kb	NULL
-	NULL
|	NULL
4	NULL
kb	NULL
-	NULL
|	NULL
3	NULL
kb	NULL
4	NULL
ko	NULL
-	NULL
oun	NULL
3	NULL
kb	NULL
Sacl	NULL
16	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
Probe	NULL
:	NULL
neo	NULL
Figure	NULL
6	NULL
-	NULL
Analysis	NULL
for	NULL
clonality	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
703	NULL
expressing	NULL
PBLs	NULL
.	NULL

Clonal	NULL
compositions	NULL
of	NULL
each	NULL
infected	NULL
PBL	NULL
were	NULL
examined	NULL
by	NULL
Southern	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
retroviral	NULL
vector	NULL
integration	NULL
site	NULL
.	NULL

Each	NULL
DNA	NULL
was	NULL
digested	NULL
with	NULL
EcoRI	NULL
,	NULL
which	NULL
cut	NULL
once	NULL
within	NULL
the	NULL
retroviral	NULL
vector	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
Southern	NULL
blot	NULL
analysis	NULL
with	NULL
neo-specific	NULL
probe	NULL
(	NULL
upper	NULL
)	NULL
DNAs	NULL
digested	NULL
with	NULL
Sacl	NULL
,	NULL
which	NULL
generates	NULL
unique	NULL
internal	NULL
band	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
,	NULL
were	NULL
also	NULL
examined	NULL
as	NULL
controls	NULL
(	NULL
lower	NULL
)	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
PBL/WT	NULL
at	NULL
1	NULL
month	NULL
post-infection	NULL
(	NULL
1	NULL
m	NULL
P.I	NULL
.	NULL
)	NULL

;	NULL
2	NULL
,	NULL
PBL/	NULL
WT	NULL
at	NULL
4	NULL
m	NULL
P.L	NULL
.	NULL

;	NULL
3	NULL
,	NULL
PBL/WT	NULL
at	NULL
6	NULL
m	NULL
P.L	NULL
.	NULL

;	NULL
4	NULL
,	NULL
PBL/WT	NULL
A-1	NULL
at	NULL
6	NULL
m	NULL
PI	NULL
.	NULL

;	NULL
5	NULL
,	NULL
PBL/WT	NULL
A-2	NULL
at	NULL
5	NULL
m	NULL
P.1	NULL
.	NULL

;	NULL
6	NULL
,	NULL
PBL/WT	NULL
A-3	NULL
at	NULL
6	NULL
m	NULL
PL	NULL
.	NULL

;	NULL
7	NULL
,	NULL
PBL/WT	NULL
A-4	NULL
at	NULL
5	NULL
m	NULL
PL	NULL
;	NULL
8	NULL
,	NULL
PBL/WT	NULL
C-1	NULL
at	NULL
5	NULL
m	NULL
P.L	NULL
;	NULL
9	NULL
,	NULL
PBL/703	NULL
at	NULL
1	NULL
m	NULL
P.L	NULL
;	NULL
10	NULL
,	NULL
PBL/703	NULL
at	NULL
5	NULL
m	NULL
P.L	NULL
;	NULL
11	NULL
,	NULL
PBL/703	NULL
at	NULL
6	NULL
m	NULL
P.I	NULL
.	NULL

;	NULL
12	NULL
,	NULL
PBL/703	NULL
A-2	NULL
at	NULL
7	NULL
m	NULL
PI	NULL
.	NULL

;	NULL
13	NULL
,	NULL
PBL/703	NULL
A-3	NULL
at	NULL
7	NULL
m	NULL
PL	NULL
.	NULL

;	NULL
14	NULL
,	NULL
PBL/703	NULL
B-2	NULL
at	NULL
7	NULL
m	NULL
PL	NULL
.	NULL

;	NULL
15	NULL
,	NULL
PBL/703	NULL
B-3	NULL
at	NULL
7	NULL
m	NULL
P.L	NULL
;	NULL
16	NULL
,	NULL
PBL/703	NULL
B-4	NULL
at	NULL
7	NULL
m	NULL
PI	NULL
.	NULL

these	NULL
cultures	NULL
contained	NULL
multiple	NULL
clones	NULL
.	NULL

At	NULL
4	NULL
or	NULL
5	NULL
months	NULL
post-infection	NULL
,	NULL
several	NULL
discrete	NULL
bands	NULL
appeared	NULL
,	NULL
and	NULL
only	NULL
one	NULL
or	NULL
two	NULL
of	NULL
these	NULL
bands	NULL
could	NULL
be	NULL
detected	NULL
at	NULL
6	NULL
months	NULL
post-infection	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
oligoclonal	NULL
to	NULL
nearly	NULL
monoclonal	NULL
expansion	NULL
of	NULL
particular	NULL
clones	NULL
occurred	NULL
during	NULL
this	NULL
culture	NULL
period	NULL
.	NULL

Such	NULL
clonal	NULL
expansions	NULL
could	NULL
also	NULL
be	NULL
observed	NULL
in	NULL
other	NULL
cultures	NULL
independently	NULL
maintained	NULL
for	NULL
5	NULL
to	NULL
7	NULL
months	NULL
after	NULL
the	NULL
infection	NULL
.	NULL

The	NULL
patterns	NULL
of	NULL
bands	NULL
differed	NULL
among	NULL
the	NULL
cultures	NULL
,	NULL
indicating	NULL
that	NULL
they	NULL
consisted	NULL
of	NULL
different	NULL
clones	NULL
.	NULL

Such	NULL
situations	NULL
were	NULL
similar	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
most	NULL
striking	NULL
difference	NULL
was	NULL
that	NULL
the	NULL
expanded	NULL
clones	NULL
were	NULL
CD4+	NULL
cells	NULL
in	NULL
wild-type	NULL
expressing	NULL
PBL	NULL
,	NULL
and	NULL
were	NULL
CD8	NULL
+	NULL
cells	NULL
in	NULL
mutant	NULL
703	NULL
expressing	NULL
PBL	NULL
.	NULL

Discussion	NULL
In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
introduced	NULL
several	NULL
Taxl	NULL
mutants	NULL
as	NULL
well	NULL
as	NULL
wild-type	NULL
which	NULL
differed	NULL
in	NULL
trans-activating	NULL
phenotypes	NULL
into	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
by	NULL
retroviral	NULL
vectors	NULL
.	NULL

The	NULL
mutants	NULL
used	NULL
were	NULL
M22	NULL
which	NULL
can	NULL
activate	NULL
the	NULL
CREB/ATF	NULL
and	NULL
SRF	NULL
pathways	NULL
but	NULL
not	NULL
the	NULL
NF-xB	NULL
pathway	NULL
,	NULL
mutant	NULL
703	NULL
which	NULL
can	NULL
activate	NULL
the	NULL
NF-xB	NULL
pathway	NULL
but	NULL
fails	NULL
to	NULL
activate	NULL
the	NULL
CREB/ATF	NULL
and	NULL
SRF	NULL
pathways	NULL
,	NULL
and	NULL
mutant	NULL
410	NULL
which	NULL
is	NULL
defective	NULL
in	NULL
all	NULL
these	NULL
pathways	NULL
.	NULL

Among	NULL
these	NULL
mutants	NULL
,	NULL
only	NULL
the	NULL
mutant	NULL
703	NULL
enhanced	NULL
the	NULL
growth	NULL
response	NULL
to	NULL
IL-2	NULL
as	NULL
wild-type	NULL
Taxl	NULL
did	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

This	NULL
analysis	NULL
was	NULL
conducted	NULL
at	NULL
1	NULL
month	NULL
post-infection	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
still	NULL
mixed	NULL
populations	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
with	NULL
no	NULL
significant	NULL
differences	NULL
in	NULL
subset	NULL
composition	NULL
in	NULL
each	NULL
infected	NULL
PBL	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
results	NULL
represented	NULL
the	NULL
general	NULL
features	NULL
of	NULL
each	NULL
mutant	NULL
Taxl	NULL
expressing	NULL
PBL	NULL
rather	NULL
than	NULL
those	NULL
of	NULL
some	NULL
particular	NULL
clones	NULL
.	NULL

The	NULL
responsiveness	NULL
of	NULL
mutant	NULL
703	NULL
expressing	NULL
PBL	NULL
was	NULL
even	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
wild-type	NULL
Taxl	NULL
expressing	NULL
PBL	NULL
,	NULL
which	NULL
probably	NULL
reflects	NULL
the	NULL
higher	NULL
expression	NULL
level	NULL
of	NULL
Taxl	NULL
protein	NULL
,	NULL
the	NULL
higher	NULL
activation	NULL
level	NULL
of	NULL
NF-xB	NULL
pathway	NULL
,	NULL
and	NULL
the	NULL
higher	NULL
incidence	NULL
of	NULL
CD25	NULL
(	NULL
IL-2R	NULL
«	NULL
)	NULL
positive	NULL
cells	NULL
in	NULL
this	NULL
culture	NULL
(	NULL
Figures	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
show	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
NF-xB	NULL
pathway	NULL
,	NULL
and	NULL
support	NULL
the	NULL
previous	NULL
notion	NULL
that	NULL
Tax1	NULL
promotes	NULL
T-cell	NULL
growth	NULL
by	NULL
inducing	NULL
CD25	NULL
(	NULL
IL-2Ra	NULL
)	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-xB	NULL
pathway	NULL
(	NULL
Franchini	NULL
,	NULL
1995	NULL
;	NULL
Yoshida	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

It	NULL
was	NULL
recently	NULL
reported	NULL
that	NULL
Taxl	NULL
can	NULL
interact	NULL
with	NULL
and	NULL
inactivate	NULL
p16	NULL
``	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
CDK4	NULL
and	NULL
CDK6	NULL
,	NULL
using	NULL
domains	NULL
that	NULL
overlap	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
xB	NULL
activation	NULL
domain	NULL
(	NULL
Suzuki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
could	NULL
not	NULL
detect	NULL
this	NULL
complex	NULL
in	NULL
our	NULL
cells	NULL
,	NULL
since	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
p16	NULL
``	NULL
is	NULL
very	NULL
low	NULL
in	NULL
T-cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
(	NULL
Tam	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
a	NULL
part	NULL
of	NULL
the	NULL
positive	NULL
effect	NULL
on	NULL
cell	NULL
growth	NULL
by	NULL
Tax1	NULL
may	NULL
be	NULL
mediated	NULL
via	NULL
this	NULL
mechanism	NULL
.	NULL

The	NULL
growth	NULL
promoting	NULL
effect	NULL
of	NULL
mutant	NULL
PBL	NULL
transduced	NULL
with	NULL
HTLV-I	NULL
Tax	NULL
mutants	NULL
T	NULL
Akagi	NULL
et	NULL
al	NULL
2076	NULL
703	NULL
was	NULL
also	NULL
demonstrated	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
only	NULL
this	NULL
mutant	NULL
led	NULL
to	NULL
the	NULL
emergence	NULL
of	NULL
continuously	NULL
growing	NULL
oligoclonal	NULL
or	NULL
monoclonal	NULL
cell	NULL
lines	NULL
after	NULL
long-term	NULL
culture	NULL
in	NULL
IL-2	NULL
containing	NULL
medium	NULL
reproducibly	NULL
,	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
as	NULL
wild-type	NULL
Taxl	NULL
.	NULL

It	NULL
is	NULL
not	NULL
yet	NULL
clear	NULL
whether	NULL
these	NULL
cells	NULL
are	NULL
fully	NULL
immortalized	NULL
or	NULL
not	NULL
,	NULL
but	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
the	NULL
ability	NULL
in	NULL
continuing	NULL
cell	NULL
growth	NULL
has	NULL
been	NULL
greatly	NULL
improved	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

By	NULL
using	NULL
the	NULL
same	NULL
type	NULL
of	NULL
Tax1	NULL
mutant	NULL
,	NULL
the	NULL
essential	NULL
role	NULL
of	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-xB	NULL
pathway	NULL
in	NULL
growth	NULL
promotion	NULL
was	NULL
also	NULL
demonstrated	NULL
in	NULL
rat	NULL
fibroblasts	NULL
recently	NULL
(	NULL
Yamaoka	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
all	NULL
the	NULL
long-term	NULL
cultures	NULL
obtained	NULL
by	NULL
the	NULL
introduction	NULL
of	NULL
mutant	NULL
703	NULL
were	NULL
CD8	NULL
+	NULL
T-cells	NULL
,	NULL
while	NULL
most	NULL
of	NULL
those	NULL
obtained	NULL
by	NULL
the	NULL
introduction	NULL
of	NULL
wild-type	NULL
Tax1	NULL
were	NULL
CD4+	NULL
T-cells	NULL
.	NULL

This	NULL
was	NULL
not	NULL
due	NULL
to	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
subset	NULL
composition	NULL
of	NULL
the	NULL
initially	NULL
infected	NULL
cell	NULL
populations	NULL
,	NULL
because	NULL
there	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
of	NULL
it	NULL
between	NULL
these	NULL
two	NULL
cell	NULL
types	NULL
at	NULL
1	NULL
month	NULL
post-infection	NULL
.	NULL

CD8	NULL
+	NULL
T-cells	NULL
have	NULL
a	NULL
higher	NULL
responsiveness	NULL
to	NULL
IL-2	NULL
than	NULL
CD4+	NULL
T-cells	NULL
intrinsically	NULL
,	NULL
and	NULL
culturing	NULL
PBL	NULL
in	NULL
IL-2	NULL
usually	NULL
results	NULL
in	NULL
predominantly	NULL
CD8	NULL
+	NULL
T-cells	NULL
(	NULL
Asano	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Gullberg	NULL
and	NULL
Smith	NULL
,	NULL
1986	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
clonal	NULL
expansion	NULL
of	NULL
CD8	NULL
+	NULL
T-cells	NULL
in	NULL
mutant	NULL
703	NULL
infected	NULL
PBL	NULL
probably	NULL
reflects	NULL
this	NULL
higher	NULL
growth	NULL
ability	NULL
of	NULL
CD8	NULL
+	NULL
T-cells	NULL
.	NULL

The	NULL
proliferation	NULL
of	NULL
CD4+	NULL
T-cells	NULL
is	NULL
much	NULL
more	NULL
strictly	NULL
regulated	NULL
than	NULL
CD8	NULL
+	NULL
T-cells	NULL
,	NULL
and	NULL
the	NULL
clonal	NULL
expansion	NULL
of	NULL
CD4+	NULL
T-cells	NULL
in	NULL
PBL	NULL
culture	NULL
has	NULL
only	NULL
been	NULL
reported	NULL
with	NULL
HTLV-I	NULL
infection	NULL
(	NULL
Gullberg	NULL
and	NULL
Smith	NULL
,	NULL
1986	NULL
)	NULL
.	NULL

Clonal	NULL
expansion	NULL
of	NULL
CD4+	NULL
T-cells	NULL
characteristically	NULL
occurs	NULL
following	NULL
HTLV-I	NULL
infection	NULL
of	NULL
PBL	NULL
,	NULL
but	NULL
the	NULL
mechanism	NULL
of	NULL
this	NULL
is	NULL
not	NULL
clear	NULL
.	NULL

Our	NULL
results	NULL
in	NULL
which	NULL
expansion	NULL
of	NULL
CD4+	NULL
T-cells	NULL
was	NULL
observed	NULL
only	NULL
in	NULL
wild-type	NULL
Taxl	NULL
expressing	NULL
PBL	NULL
but	NULL
not	NULL
in	NULL
mutant	NULL
703	NULL
expression	NULL
PBL	NULL
clearly	NULL
demonstrates	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
is	NULL
not	NULL
sufficient	NULL
and	NULL
that	NULL
activation	NULL
of	NULL
CREB/ATF	NULL
and	NULL
SRF	NULL
is	NULL
also	NULL
required	NULL
in	NULL
this	NULL
process	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
unable	NULL
to	NULL
evaluate	NULL
the	NULL
respective	NULL
roles	NULL
of	NULL
the	NULL
CREB/ATF	NULL
pathway	NULL
and	NULL
the	NULL
SRF	NULL
pathway	NULL
due	NULL
to	NULL
a	NULL
lack	NULL
of	NULL
suitable	NULL
Tax1	NULL
mutants	NULL
.	NULL

The	NULL
mechanism	NULL
underlying	NULL
the	NULL
expansion	NULL
of	NULL
CD4+	NULL
cells	NULL
is	NULL
not	NULL
clear	NULL
at	NULL
present	NULL
,	NULL
but	NULL
Wild-type	NULL
Tax1l	NULL
not	NULL
mutant	NULL
703	NULL
may	NULL
activate	NULL
some	NULL
positive	NULL
factor	NULL
on	NULL
the	NULL
growth	NULL
of	NULL
CD4+	NULL
cells	NULL
whose	NULL
effect	NULL
is	NULL
not	NULL
so	NULL
strong	NULL
considering	NULL
the	NULL
slow	NULL
time	NULL
course	NULL
of	NULL
CD4+	NULL
cell	NULL
expansion	NULL
.	NULL

Cytokines	NULL
are	NULL
supposed	NULL
to	NULL
be	NULL
a	NULL
candidate	NULL
for	NULL
such	NULL
factor	NULL
.	NULL

Many	NULL
cytokines	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
affect	NULL
the	NULL
ratio	NULL
of	NULL
CD4+	NULL
cells	NULL
and	NULL
CD8	NULL
+	NULL
cells	NULL
when	NULL
added	NULL
into	NULL
PBL	NULL
culture	NULL
in	NULL
combination	NULL
with	NULL
IL-2	NULL
(	NULL
Abe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Lee	NULL
and	NULL
Rich	NULL
,	NULL
1993	NULL
;	NULL
Soldaini	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
van	NULL
Bergen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Yang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

HTLV-I	NULL
infected	NULL
T-cells	NULL
produce	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cytokines	NULL
and	NULL
Tax1	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
this	NULL
process	NULL
(	NULL
Franchini	NULL
,	NULL
1995	NULL
;	NULL
Hollsberg	NULL
and	NULL
Hafler	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
differential	NULL
induction	NULL
of	NULL
cytokines	NULL
between	NULL
wild-type	NULL
and	NULL
mutant	NULL
703	NULL
may	NULL
explain	NULL
the	NULL
observed	NULL
expansion	NULL
of	NULL
different	NULL
subsets	NULL
of	NULL
T-cells	NULL
.	NULL

Differences	NULL
in	NULL
the	NULL
level	NULL
of	NULL
several	NULL
cytokines	NULL
in	NULL
the	NULL
culture	NULL
supernatant	NULL
from	NULL
wild-type	NULL
Tax1	NULL
expressing	NULL
PBL	NULL
and	NULL
mutant	NULL
703	NULL
expressing	NULL
PBL	NULL
was	NULL
detected	NULL
prior	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
significant	NULL
difference	NULL
in	NULL
the	NULL
CD4+	NULL
cell	NULL
population	NULL
(	NULL
Akagi	NULL
et	NULL
al	NULL
.	NULL

unpublished	NULL
data	NULL
)	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
it	NULL
is	NULL
worth	NULL
mentioning	NULL
that	NULL
many	NULL
Tax-inducible	NULL
cytokine	NULL
genes	NULL
have	NULL
motifs	NULL
of	NULL
CRE	NULL
or	NULL
AP-1	NULL
,	NULL
which	NULL
are	NULL
activated	NULL
indirectly	NULL
by	NULL
SRF	NULL
,	NULL
in	NULL
combination	NULL
with	NULL
NF-xB	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
(	NULL
Bailly	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Curtiss	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Himes	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Mori	NULL
and	NULL
Prager	NULL
,	NULL
1996	NULL
;	NULL
Mori	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994b	NULL
;	NULL
Yamashita	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Full	NULL
activation	NULL
of	NULL
these	NULL
cytokine	NULL
gene	NULL
promoters	NULL
might	NULL
only	NULL
be	NULL
achieved	NULL
by	NULL
wild-type	NULL
Taxl	NULL
.	NULL

It	NULL
was	NULL
recently	NULL
demonstrated	NULL
that	NULL
Tax-responsive	NULL
elements	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
GM-CSF	NULL
and	NULL
IL-2	NULL
are	NULL
activated	NULL
only	NULL
by	NULL
wild-type	NULL
Taxl	NULL
but	NULL
not	NULL
by	NULL
M22	NULL
nor	NULL
M47	NULL
which	NULL
corresponds	NULL
to	NULL
mutant	NULL
703	NULL
(	NULL
Curtiss	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Himes	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Good	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
and	NULL
this	NULL
is	NULL
in	NULL
sharp	NULL
contrast	NULL
to	NULL
the	NULL
promoter	NULL
of	NULL
IL-2R	NULL
«	NULL
which	NULL
is	NULL
efficiently	NULL
activated	NULL
by	NULL
mutant	NULL
703	NULL
.	NULL

Although	NULL
the	NULL
expanded	NULL
T-cell	NULL
subsets	NULL
were	NULL
different	NULL
,	NULL
clonal	NULL
selections	NULL
of	NULL
the	NULL
infected	NULL
cells	NULL
occurred	NULL
both	NULL
in	NULL
wild-type	NULL
and	NULL
mutant	NULL
703	NULL
expressing	NULL
PBLs	NULL
.	NULL

Clonal	NULL
selections	NULL
are	NULL
well-documented	NULL
in	NULL
the	NULL
course	NULL
of	NULL
in	NULL
vitro	NULL
transformation	NULL
of	NULL
T-cells	NULL
by	NULL
HTLV-I	NULL
(	NULL
Hahn	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1984	NULL
;	NULL
De	NULL
Rossi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
basis	NULL
of	NULL
this	NULL
selection	NULL
process	NULL
is	NULL
unclear	NULL
.	NULL

It	NULL
means	NULL
that	NULL
one	NULL
or	NULL
few	NULL
cells	NULL
continued	NULL
to	NULL
grow	NULL
with	NULL
a	NULL
slight	NULL
growth	NULL
advantage	NULL
over	NULL
other	NULL
cells	NULL
,	NULL
and	NULL
eventually	NULL
became	NULL
dominant	NULL
after	NULL
the	NULL
long	NULL
culturing	NULL
period	NULL
.	NULL

This	NULL
may	NULL
be	NULL
caused	NULL
by	NULL
the	NULL
differences	NULL
in	NULL
proviral	NULL
integration	NULL
site	NULL
,	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
Tax1	NULL
protein	NULL
,	NULL
or	NULL
responsiveness	NULL
to	NULL
cytokines	NULL
or	NULL
so	NULL
on	NULL
.	NULL

One	NULL
wild-type	NULL
transduced	NULL
PBL	NULL
culture	NULL
C-1	NULL
,	NULL
in	NULL
which	NULL
we	NULL
confirmed	NULL
the	NULL
expression	NULL
of	NULL
Taxl	NULL
with	NULL
wild-type	NULL
phenotype	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
showed	NULL
no	NULL
expansion	NULL
of	NULL
CD4+	NULL
cells	NULL
In	NULL
this	NULL
particular	NULL
case	NULL
,	NULL
the	NULL
TaxI1-expressing	NULL
vector	NULL
might	NULL
have	NULL
failed	NULL
to	NULL
infect	NULL
the	NULL
CD4+	NULL
T-cells	NULL
which	NULL
were	NULL
competent	NULL
for	NULL
clonal	NULL
expension	NULL
.	NULL

In	NULL
rare	NULL
instances	NULL
,	NULL
the	NULL
establishment	NULL
of	NULL
CD8	NULL
+	NULL
T-cell	NULL
lines	NULL
has	NULL
been	NULL
reported	NULL
also	NULL
in	NULL
the	NULL
case	NULL
of	NULL
HTLV-I	NULL
infection	NULL
(	NULL
Harper	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Markham	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
clearly	NULL
demonstrate	NULL
a	NULL
critical	NULL
role	NULL
of	NULL
NF-xB	NULL
activation	NULL
in	NULL
promoting	NULL
cell	NULL
growth	NULL
and	NULL
the	NULL
indispensable	NULL
role	NULL
of	NULL
CREB/ATF	NULL
and	NULL
SRF	NULL
activation	NULL
in	NULL
preferential	NULL
growth	NULL
of	NULL
CD4+	NULL
cells	NULL
.	NULL

Clonal	NULL
expansion	NULL
of	NULL
CD4+	NULL
T-cells	NULL
by	NULL
Taxl	NULL
requires	NULL
the	NULL
combination	NULL
of	NULL
these	NULL
pathways	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
cellular	NULL
target	NULL
genes	NULL
differentially	NULL
activated	NULL
by	NULL
wild-type	NULL
Taxl	NULL
and	NULL
mutant	NULL
703	NULL
should	NULL
clarify	NULL
the	NULL
precise	NULL
mechanism	NULL
of	NULL
this	NULL
process	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Plasmid	NULL
construction	NULL
Retroviral	NULL
vector	NULL
plasmid	NULL
pLXEN	NULL
was	NULL
made	NULL
from	NULL
pLXSN	NULL
(	NULL
Miller	NULL
and	NULL
Rosman	NULL
,	NULL
1989	NULL
)	NULL
by	NULL
replacement	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
with	NULL
the	NULL
encephalomyocarditis	NULL
virus	NULL
(	NULL
EMCV	NULL
)	NULL
5	NULL
nontranslated	NULL
region	NULL
containing	NULL
the	NULL
internal	NULL
ribosomal	NULL
entry	NULL
site	NULL
(	NULL
IRES	NULL
)	NULL
obtained	NULL
from	NULL
pTM1	NULL
(	NULL
Moss	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
by	NULL
PCR	NULL
.	NULL

The	NULL
complete	NULL
sequence	NULL
of	NULL
pLXEN	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
DDBJ	NULL
under	NULL
the	NULL
accession	NULL
number	NULL
D88622	NULL
.	NULL

Mutants	NULL
410	NULL
and	NULL
703	NULL
were	NULL
generated	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
wild-type	NULL
Taxl	NULL
cDNA	NULL
cloned	NULL
in	NULL
pUC/Taxl	NULL
(	NULL
Akagi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
following	NULL
the	NULL
methods	NULL
of	NULL
Smith	NULL
and	NULL
Greene	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Mutant	NULL
410	NULL
was	NULL
made	NULL
to	NULL
have	NULL
an	NULL
amino	NULL
acid	NULL
substitution	NULL
at	NULL
codons	NULL
310	NULL
and	NULL
311	NULL
from	NULL
Glu-Glu	NULL
to	NULL
Ala-Ser	NULL
,	NULL
and	NULL
mutant	NULL
703	NULL
had	NULL
an	NULL
amino	NULL
acid	NULL
substitution	NULL
at	NULL
codons	NULL
319	NULL
and	NULL
320	NULL
from	NULL
Leu-Leu	NULL
to	NULL
Arg-Ser	NULL
.	NULL

Mutations	NULL
were	NULL
confirmed	NULL
by	NULL
sequencing	NULL
.	NULL

Mutant	NULL
M22	NULL
(	NULL
Smith	NULL
and	NULL
Greene	NULL
,	NULL
1995	NULL
)	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
WC	NULL
Greene	NULL
.	NULL

Each	NULL
mutant	NULL
Tax	NULL
,	NULL
as	NULL
well	NULL
as	NULL
wild-type	NULL
Tax	NULL
,	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
Hpal-EcoRI	NULL
site	NULL
of	NULL
pLXEN	NULL
by	NULL
attaching	NULL
appropriate	NULL
linkers	NULL
at	NULL
both	NULL
ends	NULL
.	NULL

p21x5-Luc	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
Nrul-HindIII	NULL
fragment	NULL
from	NULL
pRAU3.21x5-CAT	NULL
(	NULL
Shimotohno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
which	NULL
contains	NULL
5	NULL
copies	NULL
of	NULL
Tax-responsive	NULL
21	NULL
bp	NULL
repeat	NULL
into	NULL
the	NULL
SmaI-HindIII	NULL
site	NULL
of	NULL
the	NULL
promoterless	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
PGV-B2	NULL
(	NULL
Toyo	NULL
Ink	NULL
)	NULL
.	NULL

pCArG-Lue	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
Xbal-NdelI	NULL
fragment	NULL
from	NULL
pCArG-CAT	NULL
(	NULL
Fujii	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
which	NULL
contains	NULL
a	NULL
CArG	NULL
box	NULL
derived	NULL
from	NULL
c-fos	NULL
into	NULL
the	NULL
BglII-Sacl	NULL
site	NULL
of	NULL
PGV-B2	NULL
by	NULL
attaching	NULL
appropriate	NULL
linkers	NULL
at	NULL
both	NULL
ends	NULL
.	NULL

pIL2R-Luc	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
HindIII-Sacl	NULL
fragment	NULL
from	NULL
pRPXRCAT	NULL
(	NULL
Maruyama	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
which	NULL
has	NULL
an	NULL
NF-xB	NULL
site	NULL
derived	NULL
from	NULL
human	NULL
IL-2R	NULL
&	NULL
«	NULL
chain	NULL
gene	NULL
into	NULL
the	NULL
HindIII-Sacl	NULL
site	NULL
of	NULL
PGV-B2	NULL
.	NULL

pNFxBx4-Luc	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
Nrul-HindIII	NULL
fragment	NULL
from	NULL
pNFxBx4-CAT	NULL
,	NULL
which	NULL
has	NULL
4	NULL
copies	NULL
of	NULL
an	NULL
NF-xB	NULL
site	NULL
from	NULL
the	NULL
murine	NULL
Ig	NULL
x	NULL
gene	NULL
in	NULL
Smal	NULL
site	NULL
of	NULL
pRAU3-CAT	NULL
(	NULL
Shimotohno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
,	NULL
into	NULL
the	NULL
SmaI-HindIII	NULL
site	NULL
of	NULL
PGV-B2	NULL
.	NULL

pCMV-Luc	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
Xbal-HindIII	NULL
fragment	NULL
from	NULL
pCMV-CAT	NULL
(	NULL
Akagi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
containing	NULL
the	NULL
human	NULL
cytomegalovirus	NULL
immediate	NULL
early	NULL
region	NULL
promoter	NULL
into	NULL
the	NULL
Smal-HindIII	NULL
site	NULL
of	NULL
PGV-B2	NULL
after	NULL
end	NULL
filling	NULL
the	NULL
Xbal	NULL
site	NULL
.	NULL

Cells	NULL
and	NULL
cell	NULL
culture	NULL
The	NULL
MOLT-4	NULL
(	NULL
Cheng	NULL
and	NULL
Haas	NULL
,	NULL
1990	NULL
)	NULL
,	NULL
human	NULL
T-cell	NULL
line	NULL
,	NULL
was	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
.	NULL

The	NULL
retrovirus	NULL
packaging	NULL
cell	NULL
line	NULL
PG13	NULL
(	NULL
Miller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
based	NULL
on	NULL
the	NULL
gibbon	NULL
ape	NULL
leukemia	NULL
virus	NULL
,	NULL
was	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
Modified	NULL
Eagle	NULL
's	NULL
Medium	NULL
(	NULL
DMEM	NULL
)	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
FCS	NULL
.	NULL

Primary	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
were	NULL
prepared	NULL
from	NULL
whole	NULL
fresh	NULL
blood	NULL
.	NULL

Mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
centrifugation	NULL
over	NULL
Ficoll-Hypaque	NULL
,	NULL
and	NULL
suspended	NULL
in	NULL
the	NULL
PBL	NULL
medium	NULL
:	NULL
AIM-V	NULL
medium	NULL
(	NULL
GIBCO	NULL
)	NULL
supplemented	NULL
with	NULL
2	NULL
%	NULL
FCS	NULL
,	NULL
recombinant	NULL
IL-2	NULL
at	NULL
200	NULL
u/ml	NULL
,	NULL
and	NULL
0.05	NULL
mm	NULL
2-mercaptoethanol	NULL
,	NULL
and	NULL
stimulated	NULL
with	NULL
1	NULL
%	NULL
phytohemagglu-tinin	NULL
(	NULL
PHA	NULL
)	NULL
for	NULL
3	NULL
days	NULL
.	NULL

Then	NULL
non-adherent	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
maintained	NULL
in	NULL
the	NULL
PBL	NULL
medium	NULL
for	NULL
about	NULL
a	NULL
week	NULL
.	NULL

The	NULL
surface	NULL
phenotypes	NULL
of	NULL
these	NULL
cells	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
CD3	NULL
+	NULL
,	NULL
97	NULL
%	NULL
;	NULL
CD4	NULL
+	NULL
,	NULL
30	NULL
%	NULL
;	NULL
and	NULL
CD8	NULL
+	NULL
,	NULL
70	NULL
%	NULL
.	NULL

Retroviral	NULL
infection	NULL
of	NULL
PBL	NULL
s	NULL
Each	NULL
retroviral	NULL
vector	NULL
plasmids	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
PG13	NULL
packaging	NULL
cell	NULL
line	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Akagi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

PBL	NULL
,	NULL
stimulated	NULL
with	NULL
PHA	NULL
and	NULL
expanded	NULL
in	NULL
IL-2	NULL
,	NULL
were	NULL
infected	NULL
with	NULL
retroviral	NULL
vectors	NULL
by	NULL
incubation	NULL
with	NULL
culture	NULL
supernatants	NULL
from	NULL
the	NULL
PG13	NULL
cells	NULL
,	NULL
that	NULL
had	NULL
been	NULL
filtered	NULL
through	NULL
a	NULL
0.45	NULL
um	NULL
filter	NULL
,	NULL
for	NULL
3	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
polybrene	NULL
(	NULL
8	NULL
ug/ml	NULL
)	NULL
.	NULL

Two	NULL
days	NULL
after	NULL
the	NULL
infection	NULL
,	NULL
infected	NULL
cells	NULL
were	NULL
split	NULL
into	NULL
multi	NULL
well	NULL
culture	NULL
dishes	NULL
and	NULL
selected	NULL
for	NULL
resistance	NULL
to	NULL
0.8	NULL
mg/ml	NULL
of	NULL
G418	NULL
in	NULL
the	NULL
PBL	NULL
medium	NULL
.	NULL

The	NULL
titers	NULL
of	NULL
the	NULL
retroviral	NULL
stocks	NULL
did	NULL
not	NULL
differ	NULL
significantly	NULL
between	NULL
each	NULL
Taxl	NULL
mutant	NULL
,	NULL
and	NULL
was	NULL
in	NULL
the	NULL
range	NULL
that	NULL
approximately	NULL
one	NULL
tenth	NULL
of	NULL
PBLs	NULL
could	NULL
be	NULL
infected	NULL
.	NULL

All	NULL
the	NULL
infected	NULL
PBLs	NULL
were	NULL
maintained	NULL
in	NULL
the	NULL
PBL	NULL
medium	NULL
.	NULL

Luciferase	NULL
assay	NULL
Luciferase	NULL
reporter	NULL
plasmids	NULL
were	NULL
introduced	NULL
into	NULL
T-cells	NULL
by	NULL
electroporation	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Akagi	NULL
and	NULL
Shimotohno	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

One	NULL
day	NULL
after	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
luciferase	NULL
activities	NULL
were	NULL
measured	NULL
with	NULL
References	NULL
Abe	NULL
Y	NULL
,	NULL
Van	NULL
Eden	NULL
M	NULL
,	NULL
Gatanaga	NULL
M	NULL
,	NULL
Wang	NULL
FI	NULL
,	NULL
Brightbill	NULL
HD	NULL
,	NULL
Granger	NULL
GA	NULL
and	NULL
Gatanaga	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Lymphokine	NULL
&	NULL
Cytokine	NULL
Research	NULL
,	NULL
12	NULL
,	NULL
279-283	NULL
.	NULL

PBL	NULL
transduced	NULL
with	NULL
HTLV-I	NULL
Tax	NULL
mutants	NULL
T	NULL
Akagi	NULL
et	NULL
al	NULL
the	NULL
PicaGene	NULL
luciferase	NULL
assay	NULL
system	NULL
(	NULL
Toyo	NULL
Ink	NULL
)	NULL
as	NULL
directed	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Southern	NULL
blot	NULL
analysis	NULL
Genomic	NULL
DNA	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
was	NULL
digested	NULL
with	NULL
restriction	NULL
endonucleases	NULL
,	NULL
separated	NULL
by	NULL
electrophoresis	NULL
in	NULL
0.8	NULL
%	NULL
agarose	NULL
,	NULL
and	NULL
blotted	NULL
onto	NULL
a	NULL
nylon	NULL
membrane	NULL
(	NULL
Hybond-N	NULL
,	NULL
Amersham	NULL
)	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
hybridized	NULL
with	NULL
P-labeled	NULL
neo-specific	NULL
probe	NULL
(	NULL
a	NULL
1.3	NULL
kb	NULL
HindIII-Smal	NULL
fragment	NULL
from	NULL
pZIPneoSV	NULL
(	NULL
X	NULL
)	NULL
I	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Akagi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Then	NULL
,	NULL
membranes	NULL
were	NULL
washed	NULL
in	NULL
0.2	NULL
x	NULL
SSC	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
65°C	NULL
for	NULL
1	NULL
h	NULL
and	NULL
exposed	NULL
to	NULL
X-ray	NULL
films	NULL
with	NULL
intensifying	NULL
screens	NULL
at	NULL
-70°C	NULL
.	NULL

Immunoblotting	NULL
Immunoblotting	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Akagi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995a	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
5	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
pelleted	NULL
and	NULL
lysed	NULL
in	NULL
100	NULL
ul	NULL
of	NULL
2x	NULL
SDS-PAGE	NULL
sample	NULL
buffer	NULL
.	NULL

Ten	NULL
microliters	NULL
of	NULL
each	NULL
sample	NULL
was	NULL
fractionated	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
were	NULL
electrophoreti-cally	NULL
transferred	NULL
to	NULL
Immobilon	NULL
(	NULL
Millipore	NULL
)	NULL
.	NULL

After	NULL
blocking	NULL
with	NULL
5	NULL
%	NULL
nonfat	NULL
dried	NULL
milk	NULL
in	NULL
TBST	NULL
(	NULL
10	NULL
mm	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
140	NULL
mm	NULL
NaCl	NULL
,	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
overnight	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
incubated	NULL
with	NULL
anti-Taxl	NULL
monoclonal	NULL
antibody	NULL
,	NULL
TAXYT7	NULL
(	NULL
Tanaka	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
in	NULL
TBST	NULL
for	NULL
1	NULL
h.	NULL
They	NULL
were	NULL
then	NULL
washed	NULL
extensively	NULL
with	NULL
TBST	NULL
,	NULL
incubated	NULL
for	NULL
1h	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
secondary	NULL
antibodies	NULL
,	NULL
washed	NULL
and	NULL
developed	NULL
with	NULL
the	NULL
Amersham	NULL
ECL	NULL
chemiluminescence	NULL
reagent	NULL
as	NULL
directed	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Fluorescence-activated	NULL
cell	NULL
sorter	NULL
analysis	NULL
FITC-conjugated	NULL
monoclonal	NULL
antibodies	NULL
against	NULL
CD3	NULL
(	NULL
Leud	NULL
)	NULL
,	NULL
CD4	NULL
(	NULL
Leu3a	NULL
)	NULL
,	NULL
CD8	NULL
(	NULL
Leu2a	NULL
)	NULL
,	NULL
and	NULL
CD25	NULL
(	NULL
IL-2R1	NULL
)	NULL
were	NULL
used	NULL
to	NULL
detect	NULL
the	NULL
cell-surface	NULL
markers	NULL
.	NULL

Cells	NULL
were	NULL
allowed	NULL
to	NULL
react	NULL
with	NULL
optimal	NULL
concentrations	NULL
of	NULL
these	NULL
antibodies	NULL
,	NULL
and	NULL
were	NULL
analysed	NULL
by	NULL
flow	NULL
cytometer	NULL
,	NULL
Cytoron-Absolute	NULL
(	NULL
Ortho	NULL
)	NULL
.	NULL

Cell	NULL
proliferation	NULL
assay	NULL
Cells	NULL
maintained	NULL
in	NULL
PBL	NULL
medium	NULL
(	NULL
200	NULL
u/ml	NULL
IL-2	NULL
)	NULL
were	NULL
suspended	NULL
in	NULL
AIM-V	NULL
medium	NULL
containing	NULL
2	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
cultured	NULL
in	NULL
flat	NULL
bottom	NULL
96	NULL
well	NULL
plates	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
well	NULL
)	NULL
for	NULL
24	NULL
h.	NULL
Then	NULL
IL-2	NULL
was	NULL
added	NULL
to	NULL
each	NULL
well	NULL
at	NULL
10	NULL
u/ml	NULL
.	NULL

Cell	NULL
proliferation	NULL
was	NULL
assayed	NULL
just	NULL
prior	NULL
to	NULL
,	NULL
and	NULL
at	NULL
3	NULL
and	NULL
6	NULL
days	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
IL-2	NULL
by	NULL
MTS	NULL
colorimetric	NULL
method	NULL
using	NULL
CellTiter96	NULL
``	NULL
``	NULL
AQueous	NULL
assay	NULL
kit	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
averages	NULL
of	NULL
triplicates	NULL
.	NULL

Acknowledgements	NULL
We	NULL
thank	NULL
Dr	NULL
M	NULL
Fujii	NULL
(	NULL
Tokyo	NULL
Medical	NULL
and	NULL
Dental	NULL
University	NULL
)	NULL
and	NULL
Dr	NULL
M	NULL
Seiki	NULL
(	NULL
Kanazawa	NULL
University	NULL
)	NULL
for	NULL
providing	NULL
pCArG-CAT	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr	NULL
WC	NULL
Greene	NULL
and	NULL
Dr	NULL
J	NULL
Elwood	NULL
(	NULL
University	NULL
of	NULL
California	NULL
San	NULL
Francisco	NULL
)	NULL
for	NULL
providing	NULL
the	NULL
Tax	NULL
M22	NULL
mutant	NULL
expression	NULL
vector	NULL
,	NULL
and	NULL
Dr	NULL
T	NULL
Sekine	NULL
(	NULL
National	NULL
Cancer	NULL
Center	NULL
)	NULL
for	NULL
supplying	NULL
recombinant	NULL
IL-2	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
Grants-in-Aid	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
Grants-in-Aid	NULL
for	NULL
a	NULL
2nd-term	NULL
Comprehensive	NULL
10-year	NULL
Strategy	NULL
for	NULL
Cancer	NULL
Control	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Health	NULL
and	NULL
Welfare	NULL
of	NULL
Japan	NULL
,	NULL
and	NULL
Grants-in-Aid	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
and	NULL
Culture	NULL
.	NULL

Akagi	NULL
T	NULL
,	NULL
Nyunoya	NULL
H	NULL
and	NULL
Shimotohno	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Gene	NULL
,	NULL
106	NULL
,	NULL
255-259	NULL
,	NULL
2077	NULL
PBL	NULL
transduced	NULL
with	NULL
HTLV-I	NULL
Tax	NULL
mutants	NULL
T	NULL
Akagi	NULL
et	NULL
al	NULL
2078	NULL
Akagi	NULL
T	NULL
,	NULL
Ono	NULL
H	NULL
,	NULL
Sasaki	NULL
T	NULL
and	NULL
Shimotohno	NULL
K.	NULL
(	NULL
1995a	NULL
)	NULL
.	NULL

FEBS	NULL
Letters	NULL
,	NULL
358	NULL
,	NULL
34-38	NULL
.	NULL

Akagi	NULL
T	NULL
,	NULL
Ono	NULL
H	NULL
and	NULL
Shimotohno	NULL
K.	NULL
(	NULL
1995b	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
86	NULL
,	NULL
4243-4249	NULL
,	NULL
Akagi	NULL
T	NULL
,	NULL
Ono	NULL
H	NULL
and	NULL
Shimotohno	NULL
K.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
12	NULL
,	NULL
1645-1652	NULL
.	NULL

Akagi	NULL
T	NULL
and	NULL
Shimotohno	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Journal	NULL
of	NULL
Virology	NULL
,	NULL
67	NULL
,	NULL
1211-1217	NULL
.	NULL

Asano	NULL
M	NULL
,	NULL
Ishida	NULL
Y	NULL
,	NULL
Sabe	NULL
H	NULL
,	NULL
Kondo	NULL
M	NULL
,	NULL
Sugamura	NULL
K	NULL
and	NULL
Honjo	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Journal	NULL
of	NULL
Immunology	NULL
,	NULL
153	NULL
,	NULL
5373-5381	NULL
.	NULL

Bailly	NULL
S	NULL
,	NULL
Fay	NULL
M	NULL
,	NULL
Israel	NULL
N	NULL
and	NULL
Gougerot-Pocidalo	NULL
MA	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

European	NULL
Cytokine	NULL
Network	NULL
,	NULL
7	NULL
,	NULL
125-128	NULL
.	NULL

Cereseto	NULL
A	NULL
,	NULL
Diella	NULL
F	NULL
,	NULL
Mulloy	NULL
JC	NULL
,	NULL
Cara	NULL
A	NULL
,	NULL
Michieli	NULL
P	NULL
,	NULL
Grassmann	NULL
R	NULL
,	NULL
Franchini	NULL
G	NULL
&	NULL
Klotman	NULL
ME	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
88	NULL
,	NULL
1551-1560	NULL
.	NULL

Cheng	NULL
J	NULL
and	NULL
Haas	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Molecular	NULL
&	NULL
Cellular	NULL
Biology	NULL
,	NULL
10	NULL
,	NULL
5502-5509	NULL
.	NULL

Curtiss	NULL
VE	NULL
,	NULL
Smilde	NULL
R	NULL
and	NULL
McGuire	NULL
KL	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Molecular	NULL
&	NULL
Cellular	NULL
Biology	NULL
,	NULL
16	NULL
,	NULL
3567-3575	NULL
.	NULL

De	NULL
Rossi	NULL
A	NULL
,	NULL
Aldovini	NULL
A	NULL
,	NULL
Franchini	NULL
G	NULL
,	NULL
Mann	NULL
D	NULL
,	NULL
Gallo	NULL
RC	NULL
&	NULL
Wong-Staal	NULL
F.	NULL
(	NULL
1985	NULL
)	NULL
.	NULL

Virology	NULL
,	NULL
143	NULL
,	NULL
640-645	NULL
.	NULL

Feuer	NULL
G	NULL
&	NULL
Chen	NULL
IS	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Biochimica	NULL
et	NULL
Biophysica	NULL
Acta	NULL
,	NULL
1114	NULL
,	NULL
223-233	NULL
.	NULL

Franchini	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
86	NULL
,	NULL
3619-3639	NULL
.	NULL

Fujii	NULL
M	NULL
,	NULL
Tsuchiya	NULL
H	NULL
,	NULL
Chubjo	NULL
T	NULL
,	NULL
Akizawa	NULL
T	NULL
&	NULL
Seiki	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Genes	NULL
&	NULL
Development	NULL
,	NULL
6	NULL
,	NULL
2066-2076	NULL
.	NULL

Good	NULL
L	NULL
,	NULL
Maggirwar	NULL
SB	NULL
&	NULL
Sun	NULL
SC	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
15	NULL
,	NULL
3744-3750	NULL
.	NULL

Grassmann	NULL
R	NULL
,	NULL
Berchtold	NULL
S	NULL
,	NULL
Radant	NULL
I	NULL
,	NULL
Alt	NULL
M	NULL
,	NULL
Fleckenstein	NULL
B	NULL
,	NULL
Sodroski	NULL
JG	NULL
,	NULL
Haseltine	NULL
WA	NULL
&	NULL
Ramstedt	NULL
U	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Journal	NULL
of	NULL
Virology	NULL
,	NULL
66	NULL
,	NULL
4570-4575	NULL
.	NULL

Gullberg	NULL
M	NULL
&	NULL
Smith	NULL
KA	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
.	NULL

Journal	NULL
of	NULL
Experimental	NULL
Medicine	NULL
,	NULL
163	NULL
,	NULL
270-284	NULL
.	NULL

Hahn	NULL
B	NULL
,	NULL
Gallo	NULL
RC	NULL
,	NULL
Franchini	NULL
G	NULL
,	NULL
Popovic	NULL
M	NULL
,	NULL
Aoki	NULL
T	NULL
,	NULL
Salahuddin	NULL
SZ	NULL
,	NULL
Markham	NULL
PD	NULL
&	NULL
Staal	NULL
FW	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
.	NULL

Molecular	NULL
Biology	NULL
&	NULL
Medicine	NULL
,	NULL
2	NULL
,	NULL
29-36	NULL
.	NULL

Harper	NULL
ME	NULL
,	NULL
Kaplan	NULL
MH	NULL
,	NULL
Marselle	NULL
LM	NULL
,	NULL
Pahwa	NULL
SG	NULL
,	NULL
Chayt	NULL
KJ	NULL
,	NULL
Sarngadharan	NULL
MG	NULL
,	NULL
Wong-Staal	NULL
F	NULL
and	NULL
Gallo	NULL
RC	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
.	NULL

New	NULL
England	NULL
Journal	NULL
of	NULL
Medicine	NULL
,	NULL
315	NULL
,	NULL
1073-1078	NULL
.	NULL

Higashimura	NULL
N	NULL
,	NULL
Takasawa	NULL
N	NULL
,	NULL
Tanaka	NULL
Y	NULL
,	NULL
Nakamura	NULL
M	NULL
and	NULL
Sugamura	NULL
K.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Japanese	NULL
Journal	NULL
of	NULL
Cancer	NULL
Research	NULL
,	NULL
87	NULL
,	NULL
227-231	NULL
.	NULL

Himes	NULL
SR	NULL
,	NULL
Coles	NULL
LS	NULL
,	NULL
Katsikeros	NULL
R	NULL
,	NULL
Lang	NULL
RK	NULL
and	NULL
Shannon	NULL
MF	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
8	NULL
,	NULL
3189-3197	NULL
.	NULL

Hollsberg	NULL
P	NULL
and	NULL
Hafler	NULL
DA	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

New	NULL
England	NULL
Journal	NULL
of	NULL
Medicine	NULL
,	NULL
328	NULL
,	NULL
1173-1182	NULL
.	NULL

Lee	NULL
HM	NULL
and	NULL
Rich	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Journal	NULL
of	NULL
Immunology	NULL
,	NULL
151	NULL
,	NULL
668-677	NULL
.	NULL

Markham	NULL
PD	NULL
,	NULL
Salahuddin	NULL
SZ	NULL
,	NULL
Macchi	NULL
B	NULL
,	NULL
Robert-Guroff	NULL
M	NULL
and	NULL
Gallo	NULL
RC	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
.	NULL

International	NULL
Journal	NULL
of	NULL
Cancer	NULL
,	NULL
33	NULL
,	NULL
13-17	NULL
.	NULL

Maruyama	NULL
M	NULL
,	NULL
Shibuya	NULL
H	NULL
,	NULL
Harada	NULL
H	NULL
,	NULL
Hatakeyama	NULL
M	NULL
,	NULL
Seiki	NULL
M	NULL
,	NULL
Fujita	NULL
T	NULL
,	NULL
Inoue	NULL
J	NULL
,	NULL
Yoshida	NULL
M	NULL
and	NULL
Taniguchi	NULL
T.	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
48	NULL
,	NULL
343-350	NULL
.	NULL

Miller	NULL
AD	NULL
,	NULL
Garcia	NULL
JV	NULL
,	NULL
von	NULL
Suhr	NULL
N	NULL
,	NULL
Lynch	NULL
CM	NULL
,	NULL
Wilson	NULL
C	NULL
and	NULL
Eiden	NULL
MV	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Journal	NULL
of	NULL
Virology	NULL
,	NULL
65	NULL
,	NULL
2220-2224	NULL
.	NULL

Miller	NULL
AD	NULL
and	NULL
Rosman	NULL
GJ	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

Biotechniques	NULL
,	NULL
7	NULL
,	NULL
980	NULL
982	NULL
.	NULL

Mori	NULL
N	NULL
,	NULL
Murakami	NULL
S	NULL
,	NULL
Oda	NULL
S	NULL
and	NULL
Eto	NULL
S.	NULL
(	NULL
1994a	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
84	NULL
,	NULL
350-351	NULL
.	NULL

Mori	NULL
N	NULL
&	NULL
Prager	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
87	NULL
,	NULL
3410-3417	NULL
.	NULL

Mori	NULL
N	NULL
,	NULL
Shirakawa	NULL
F	NULL
,	NULL
Shimizu	NULL
H	NULL
,	NULL
Murakami	NULL
S	NULL
,	NULL
Oda	NULL
S	NULL
,	NULL
Yamamoto	NULL
K	NULL
and	NULL
Eto	NULL
S.	NULL
(	NULL
1994b	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
84	NULL
,	NULL
2904-2911	NULL
.	NULL

Moss	NULL
B	NULL
,	NULL
Elroy-Stein	NULL
O	NULL
,	NULL
Mizukami	NULL
T	NULL
,	NULL
Alexander	NULL
WA	NULL
and	NULL
Fuerst	NULL
TR	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
348	NULL
,	NULL
91-92	NULL
.	NULL

Ohbo	NULL
K	NULL
,	NULL
Takasawa	NULL
N	NULL
,	NULL
Ishii	NULL
N	NULL
,	NULL
Tanaka	NULL
N	NULL
,	NULL
Nakamura	NULL
M	NULL
and	NULL
Sugamura	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Journal	NULL
of	NULL
Biological	NULL
Chemistry	NULL
,	NULL
270	NULL
,	NULL
7479-7486	NULL
.	NULL

Shimotohno	NULL
K	NULL
,	NULL
Takano	NULL
M	NULL
,	NULL
Teruuchi	NULL
T	NULL
and	NULL
Miwa	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
.	NULL

Proceedings	NULL
of	NULL
the	NULL
National	NULL
Academy	NULL
of	NULL
Sciences	NULL
of	NULL
the	NULL
United	NULL
States	NULL
of	NULL
America	NULL
,	NULL
83	NULL
,	NULL
8112-8116	NULL
.	NULL

Smith	NULL
MR	NULL
and	NULL
Greene	NULL
WC	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Genes	NULL
&	NULL
Development	NULL
,	NULL
4	NULL
,	NULL
1875-1885	NULL
.	NULL

Smith	NULL
MR	NULL
and	NULL
Greene	NULL
WC	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
,	NULL
88	NULL
,	NULL
1038-1042	NULL
.	NULL

Smith	NULL
MR	NULL
and	NULL
Greene	NULL
WC	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Genes	NULL
&	NULL
Development	NULL
,	NULL
9	NULL
,	NULL
2324	NULL
.	NULL

Soldaini	NULL
E	NULL
,	NULL
MacDonald	NULL
HR	NULL
and	NULL
Nabholz	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

European	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
22	NULL
,	NULL
1707-1711	NULL
.	NULL

Suzuki	NULL
T	NULL
,	NULL
Kitano	NULL
S	NULL
,	NULL
Matsushime	NULL
H	NULL
and	NULL
Yoshida	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
15	NULL
,	NULL
1607-1614	NULL
.	NULL

Tam	NULL
SW	NULL
,	NULL
Shay	NULL
JW	NULL
and	NULL
Pagano	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Cancer	NULL
Research	NULL
,	NULL
54	NULL
,	NULL
5816-5820	NULL
.	NULL

Tanaka	NULL
Y	NULL
,	NULL
Yoshida	NULL
A	NULL
,	NULL
Tozawa	NULL
H	NULL
,	NULL
Shida	NULL
H	NULL
,	NULL
Nyunoya	NULL
H	NULL
and	NULL
Shimotohno	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

International	NULL
Journal	NULL
of	NULL
Cancer	NULL
,	NULL
48	NULL
,	NULL
623-630	NULL
.	NULL

Tatewaki	NULL
M	NULL
,	NULL
Yamaguchi	NULL
K	NULL
,	NULL
Matsuoka	NULL
M	NULL
,	NULL
Ishii	NULL
T	NULL
,	NULL
Miyasaka	NULL
M	NULL
,	NULL
Mori	NULL
S	NULL
,	NULL
Takatsuki	NULL
K	NULL
and	NULL
Watanabe	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
86	NULL
,	NULL
3109-3117.	NULL
van	NULL
Bergen	NULL
CA	NULL
,	NULL
Smit	NULL
WM	NULL
,	NULL
van	NULL
Sluijters	NULL
DA	NULL
,	NULL
Rijnbeek	NULL
M	NULL
,	NULL
Willemze	NULL
R	NULL
and	NULL
Falkenburg	NULL
JH	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Annals	NULL
of	NULL
Hematology	NULL
,	NULL
72	NULL
,	NULL
245-252	NULL
.	NULL

Yamaoka	NULL
S	NULL
,	NULL
Inoue	NULL
H	NULL
,	NULL
Sakurai	NULL
M	NULL
,	NULL
Sugiyama	NULL
T	NULL
,	NULL
Hazama	NULL
M	NULL
,	NULL
Yamada	NULL
T	NULL
and	NULL
Hatanaka	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
15	NULL
,	NULL
873-887	NULL
.	NULL

Yamashita	NULL
I	NULL
,	NULL
Katamine	NULL
S	NULL
,	NULL
Moriuchi	NULL
R	NULL
,	NULL
Nakamura	NULL
Y	NULL
,	NULL
Miyamoto	NULL
T	NULL
,	NULL
Eguchi	NULL
K	NULL
and	NULL
Nagataki	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
84	NULL
,	NULL
1573-1578	NULL
.	NULL

Yang	NULL
SC	NULL
,	NULL
Owen-Schaub	NULL
LB	NULL
,	NULL
Roth	NULL
JA	NULL
and	NULL
Grimm	NULL
EA	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Cancer	NULL
Research	NULL
,	NULL
50	NULL
,	NULL
3526-3532	NULL
.	NULL

Yoshida	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Trends	NULL
in	NULL
Microbiology	NULL
,	NULL
1	NULL
,	NULL
131-135	NULL
.	NULL

